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SUMMARY 
The D-domain of fibrin(ogen) was separated from the parent 
molecule by plasmin digestion in the presence of calcium and 
isolated by means of DEAE-anion exchange chromatography followed 
by gel-filtration in buffer containing 4 M urea. Fluorescent-D-
dimer (f-D-dimer) was isolated from a plasmic digest of fibrin 
clotted in the presence of 2.45 mM dansyl cadaverine, a 
fluorescent lysine analogue. Fluorescent-D-monomer was a 
by-product of f-D-dimer purification, the yield being determined 
by the concentration of dansyl cadaverine. At 2 . 45 mM 
f-D-monomer was always present in the digest. The f-D-monomer is 
probably formed directly and not as a result of degradation of 
f-D-dimer. The molecule elutes in the fibrinogen-derived-
D-monomer position on gel-filtration. 
A protease was isolated and partially purified from venom of the 
puffadder {Bitis arietans). Puffadder venom protease is 
characterized by its ability to cleave D-dimer into symmetrical 
D-monomers, , smaller than plasmin-derived D-monomers from 
fibrinogen. This characteristic was used to detect the puffadder 
venom protease activity with fluorescent-D-dimer being used as 
the substrate. Fractions obtained were assayed for D-dimer 
cleavage activity and the samples analyzed by means of SDS-PAGE 
on 4-20% gradient gels under reducing '.foME) a~d non-reducing 
conditions . The fluorescent bands were located under u.v light 
and photographed prior to staining with Coomassie Blue. 
Several methods for the purification of the protease were 
investigated. Cation exchange chromatography on CM-cellulose at 
pH 5.2 proved to be unsatisfactory. Gel filtration on Ultrogel 
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AcA 34 and Sephadex G 100 gave similar separations and fractions 
with D-dimer cleavage activity were located in a peak containing 
proteins of molecular weight less than 40,000 daltons. The 
fractions from this peak wer e pooled, dialysed and subjected to 
anion exchange chromatography on DEAE-cellulose. The active 
fractions were also fractionated by a second gel-filtration step 
on Ultrogel AcA 54. High performance liquid chromatography using 
a molecular sieving column revealed that the protein capable of 
cleaving fluorescent and non-fluorescent D-dimer had a molecular 
weight~ 25,000 daltons and was associated with smaller proteins. 
Crude puffadder venom was able to hydrolyse casein, the serine 
protease substrate Chromozym TH (Boehringer) as well as cleaving 
D-dimer. The purified protein was able to hydolyse casein and 
cleave D-dimer but was not active against Chromozyms PL, PK, TRY 
or TH, as well as TAME, BTEE and ATEE. The D-dimer cleavage 
activity of the crude and purified enzyme could be completely 
inhibited by EDTA. The purified enzyme was not inhibited by the 
usual serine protease inhibitors such as PMSF or protease 
inhibitors of bacterial origin. Addition of low concentrations 
of zinc potentiated D-dimer cleavage activity of the enzyme at 
least tenfold. 
Collection of the venom into EDTA completely destroyed D-dimer 
cleavage activity. No further attempt was made to purify the 
enzyme for fear of removing the zinc moeity that was found to be 
essential for D-dimer cleavage activity. 
The purified enzyme was utilised in the study of the cross-link 
site in the D-domain of fibrin. Cleavage of f-D-dimer by the 
14 
enzyme resulted in two symmetrical monomers - called 
D-PAV-monomer - that was smaller than plasmin D-monomer from 
fibrinogen. The earliest event in the action of PAV protease 
appears to b e th e cleavage of the di-gamma bond with the 
production o f on ly on e size oft-species, either fluorescent or 
non-fluorescent, with separation of the dimer into monomers. This 
was suggestive of an 'isopeptidase' activity. The }-chain is 
hydrolysed at a slower rate and this is a progressive process 
yielding a smaller chain size (}-PAV). Early in the digestion of 
D-dimer, two species of D-monomers are seen, suggesting that 
cleavage of the di-gamma bond can precede and be independent of 
the progressive reduction in size of the ft-chain (that determines 
the smaller D-monomer species). D-PAV-monomer was utilized in 
the study of the cross-link site of fibrin. 
D-PAV-monomer was prepared by digestion with PAV protease of non-
fluorescent D-dimer to which was added a small amount (1:100) of 
fluorescent D-monomer as marker to facilitate location of the 
1-chain in the subsequent manipulations of the molecule. The 
D-PAV-monomer was isolated from the PAV protease digest by 
DEAE-anion exchange chromatography. 
The D-PAV-monomer was reduced and alkylated and the }{-chains 
isolated by means of anion exchange chromatography on DEAE-
cellulose CL 6B in buffer containing SM urea. 
The ~-chains were cleaved with cyanogen bromide and the peptides 
isolated by gel-filtration on Sephadex G50 in 10% acetic acid. 
The carboxy-terminal peptide was located by means of the 
fluorescence after evaporation of the acid solvent and the 
addition of ammonium bicarbonate and the peptide was finally 
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purified by means of high performance liquid chromatography. 
This peptide could be identified by means of the known 
composition of the post-methionine peptides and this was 
facilitated by the unique absence o f serine. The peptide was 
sequenced by a manual gas-phase microsequencing technique and the 
results checked with automated gas-phase microsequencing. 
The sequence found revealed two amino-terminal residues and two 
sequences for 7 residues and thereafter a single sequence. 
comparison with the expected linear sequence of the carboxy-
terminal post-methionine peptide allowed the site of cleavage to 
be clearly identified as occuring before the alanine, 7 residues 
from the carboxy-terminal end, with a slightly heterogeneous loss 
of about 4 to 6 residues on the aminoterminal side of this 
alanine between the crosslinked glutamines (13 or 14) and the 
lysine, 6 residues from the carboxy-terminus. 
The expected peptide sequence is :-
M 385 KI IP F N R LT I GE G Q
 Q H H LG GA K QA GD v 411 
but the sequence found could be resolved by inspection as :-
* * 
385 KI I p F N R L T I G E G Q Q 8 400 either 
405 A t Q A G D V411 K 
* 
[where ( *) indicates a cross-link site). There is therefore 
Q 
a (heterogeneous) loss of 401 
H LG G
406 
and possibly also 
399
0 and 
400H in subfractions of the pep
tide. 
The loss of amino acids between the cross-link sites suggests 
that PAV protease cleaves D-dimer by means of hydrolysis of a 
peptide bond between the cross-link sites, and not by hydrolysis 
through the 'iso-peptide' bond, as was originally suggested. 
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The results were unexpected, in that contrar y to current dogma, 
the major partner in the (i-glutamyl)-(€-lysine) reciprocal 
cross-lin k of fibrin would appear to be predominantly residue 
glutamine ~-399 with minor involvement of glutamine i-398. 
The susceptibility of rat and bovine D-dimer to cleavage suggests 
that the consensus site for cleavage might lie on the carboxy-
terminal side of the two glycines, 8 and 9 residues from the end 
and between the reciprocal crosslinks. The loss of about 4 to 6 
residue s from between the crosslinked residues may be due to 
carboxypeptidase activities of the protease or a contaminant. 
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1 INTRODUCTION 
1.1 ASPECTS OF FIBRINOGEN STRUCTURE AND FUNCTION 
Proteins in general are members of two classes - soluble and 
insoluble proteins eg. globular c y topl asmic and blood plasma 
proteins and insoluble membrane and fibrous proteins. There are 
few proteins that exist in both forms. Fibronectin is an example 
of a protein that has a major role as an integral membrane 
protein promoting cell anchorage, migration and differentiation 
(Yamada and Kennedy, 1979), and is also present in small amounts 
(3 mg%) as a soluble plasma protein. Whether the soluble form 
contributes to cell anchorage in vitro is still uncertain, 
althoug h it does promote cell anchorage in tissue culture. 
Fibrinogen appears to be unique in that it is present in large 
amounts (200-400 mg%) in blood in a soluble form and is capable 
of increasing in times of increased demand and yet can readily 
be converted to an insoluble covalently stabilized fibrous form 
by activation of the zymogens of the coagulation cascade. An 
unique fibrous protein indeed since it carries within its 
structure the seeds of its own destruction in the form of plasmin 
susceptible sites and the anticipatory binding of the inactive 
plasmin zymogen - plasminogen (Varadi and Patthy, 1983; 
Lewis et al, 1984). 
Fibrinogen is one of the most ancient multichain proteins, 
present in all vertebrates from the lamprey to man, and arose 
more than 450 million years ago. All the evidence points to the 
evolution of the three genes, coding for the fibrinogen chains 
from one ancestral gene (Doolittle et al, 1976; Kant et al, 1983; 
Kant et al, 1985). Fibrinogen similar to the vertebrate type 
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has not been in found in vertebrates or protochordates. 
coagulable proteins are found in invertebrates (Fuller and 
Doolittle, 1971) but they are not related to fibrinogen and are 
not activated by thrombin. In common with most large proteins 
that have a well-defined function eg. haemoglobin, the fibrinogen 
molecule has s~veral domains through which multiple functions of 
the molecule are mediated. In addition coagulation of the 
protein involves interactions between the domains. Fibrinogen is 







(Figure 1). Electron microscopy has 
demonstrated details of the gross domainal structure of the 
molecule with electronmicrographs depicting the trinodular 
structure of the fibrinogen molecule that has stood the test of 
time. More recent work confirms the original model of Hall and 
Slayter (1959); Fowler et al, 1979; Ericson and Fowler, 1983; 
Slayter, 1983). The central E domain of the molecule is flanked 
by two larger distal D-domains consisting of the carboxy-terminal 
ends of the chains. The D-domains are connected to the E-domain 
by a rod-like system of interdomainal 'coiled-coils' formed by 
each of the three chains in alpha helical conformation wrapped 
around each other (Doolittle,1978). The set of proteins 
originally grouped by similar X-ray diffraction patterns, called 
the 'kmef' group (keratin- myosin- epidermin- fibrinogen), have 
in common regions of helical super coiling (Baily et al, 1943). 
The 'coiled coils' of fibrinogen begin in the E domain, relax 
centrally at the site of plasmic interdomainal cleavages, re-coil 










---230 A--~ C F 
D 
~------- ~50 A------__.~ 
Diagram of vertebrate fibrinogen molecule. 
( Doolittle,1983 
E domain with fibrinopeptides. 
t-chain carbohydrate cluster. 
interdomainal connector made up of the three 
chains forming a coiled-coil. 
D domain. 
ft-chain carbohydrate cluster. 
carboxy-terminal end of the i-chain containing 
the cross-linking site. 
"*chain carboxy-terrninal extension. 
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for the three chains are compatible with the formation of such 
helices (Doolittle et al, 1978; Plow et al, 1983). The carboxy-
terminal ends of the alpha chains have long extensions that lie 
outside the D-domains. The difficulties in crystallizing 
fibrinogen are due to these alpha chain extensions lacking a 
defined conformation. The packing or disposition of this 
extension is still controversial. Ericson and Fowler, (1983) 
using electron microscopy have demonstrated the presence of an 
extra central nodule smaller than the E-nodule. This nodule is 
always missing in fragment X where the «<(-c hain extensions have 
been cleaved by plasmin. Shrager et al, (1976) postulate that the 
car boxy-terminal ends of the «'.-chain are therefore folded back 
over the E-domain forming a protective 'umbrella' protecting it 
against proteolytic attack from enzymes other than thrombin. An 
alternative possibility is that the a.chain extension may be 
flexible and lie free outside the confines of the D-domain 
(Doolittle, 1973). Cierniewski et al, (1984) have shown that 
the carboxy-terminal regions of the Aa(;-chains are surface 
oriented with systematic ordering of the tertiary structure. 
Using antibody probes they demonstrated several surface epitopes 
present in native fibrinogen, as well as several cryptic epitopes 
that are exposed after digestion of fibrinogen by plasmin. 
The six peptide chains in fibrinogen are peld together by a 
series of 29 inter and intra-chain disulphide bonds. (Henschen, 
1978; Henschen et al, 1983). The two halves of the dimeric 
molecule are connected by 3 of 11 disulphide bridges in the 
central E domain of the molecule with 8 interchain disulphide 
bridges forming the so-called N-terminal disulphide knot - NDSK 
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(Blomback et al, 1968). In each of the two D-domains there are 
six-disulphide bridges connecting the chains, the remaining six 
disulphid e bridges bei ng intra-chain found at the carboxy-
terminal ends o f th e chains (Figure 2). Hoeprich and Doolittle 
(1983) postulate that the two halves of the dimeric molecule are 
joined by the disulphide bonds in an anti-parallel orientation. 
1.2 AMINO ACID SEQUENCE OF THE ALPHA, BETA AND GAMMA CHAINS. 
In the mid 1970's, the most important advance in the 
elucidation of structure and function of fibrinogen was the 
complete determination of the amino acid sequence of the three 
chains of fibrinogen. Cyanogen bromide treatment of whole 
fibrinogen resulted in a large number of fragments from which the 
N-terminal disulphide knot was isolated and purified, and the 
amino acid sequence determined (Blomback et al, 1972; 
Blomback et al, 1973). 
The three chains were isolated after reduction and 
alkylation of fibrin(ogen) and chromatography on CM cellulose 
with elution order of i-f-8(;-chains (McDonagh et al, 1972). 
Chemical cleavage of the chains was achieved by digestion of 
methionyl bonds with cyanogen bromide resulting in peptides that 
were isolated and purified by gel filtration. These peptides 
were studied further using enzymes such as trypsin, plasmin and 
carboxypeptidases. By means of sequencing overlapping peptides 
using various techniques such as Edman degradation, enzyme 
digestion and total amino acid analysis, the entire sequence of 
all three chains was elucidated:- alpha -chain (Blomback et al, 
22 
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Figure 2. Primary structure model of human fibrinogen 
(Henschen,1983). 
The chains are aligned according to homology, the 
N-terminal ends proximal and the C-terminal ends 
distal. The connecting lines represent disulphide 
bridges, the arrows thrombin cleavage sites and the 
diamonds carbohydrate side chains. On the left side 
of the model the disulphide knots formed by cyanogen 
bromide cleavage are white, on the right side of the 
model the plasmic fragments E and Dare white. 
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1972; Takagi and Doolittle, 1975; Cottrell and Doolittle, 1976; 
Doolittle et al, 1977, a, band c; Lottspeich and Henschen, 
1978, 1979; Doolittle et al, 1979). The beta chain (Henschen 
end Lottspeich, 1977) and the gamma-chain (Blomback et al, 1973, 
LOttspeich and Henschen, 1977a and b) (Figure 3). Recent work by 
Kolfenstein-Todel and Mosesson, (1980) has confirmed the presence 
of a ~-chain variant in normal human plasma fibrinogen found by 
Francis et al, (1980). The i'- (Yb)-chain is larger than the 
i- (ta)-chain having a carboxy-terminal extension of 16 amino acids 
accounting for their more negative charge and larger size. The 
carboxy-terminal amino acid in the ia-chains is valine while that 
of the ~b-chain variant is leucine. The chain functions normally 
*ith regard to cross-linking and polymerization. This ~-chain 
variant is found only in plasma fibrinogen and not in platelet 
=ibrinogen which has only the smaller form of ~-chains 
(Mosesson et al, 1984). 
1.3 HOMOLOGIES BETWEEN CHAINS AND INTERSPECIES HOMOLOGIES 
All vertebrates from the primitive lamprey to man have 
:ibrinogen composed of three pairs of non-identical chains -
A~ Bft2 i2 - and all are converted to fibrin on removal of 
amino-terminal fibrinopeptides A and B by thrombin. The amino 
acid sequences of the three polypeptide chains are similar enough 
to suggest that they arose from a common ancestor (Doolittle , 
1983). If the three chains are aligned with their cysteines in 
register, the similarity between the three chains becomes very 
clear . The most obvious differences between the chains are the 
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A ol. 
A O S G E G O F L A E O G G V R~G P R V V E R Li O S A 
C K D S D W P F C S O E 0 
41 w HY KC PS G CRH KG LI DEV NOD FT N R N KL K
N SL FEY a KN N 
81 KOSH SL TT NIH E I LR GO F SSA N N RON
 TY N RVS ED LR SR I E 
121 VLK R KV I EK V ~ H O LL OK NVR A Q L VO
 HK R LEV DI DI KI RS 
161 CR GS CSR AL ARE VD L k DYE O Q OK Q L '
E Q VI AK D LL P ~SD R Q 
201 H LPL I K HK P VP D L VP OH F k SQ L Q kV 
PP E Wk ALT b MP a MR M 
241 EL ERP G G NE I TR G GS TS Y GT GS ET E
SP RN PSS AG SW NS G(G) 
281 §GP G(G)T G N RN PG S SGT G GT AT WK PG 
S S GP GS T GS W NS GS S 
321 GT GS T G HON PG SP RPG ST GT WNP GS 
SER GS AG Y WT SES S V 
361 SGS T GO w HS ES GS FR PO SP GS G NA RP N NP 
D W GT FEE VS G N 
401 VS PG TR REY HT EK L VT SK GO KE LR T 
GK EK VT SGS TT TT RR 
441 SC SK TV T KT VI GPO G HK EV T KEV VT 
SEO GS DC PE AHO LG T 
4RI LS GIG TL O G FR HRH POE A AF F OT AST
 GK T F PG FF SP ML GE 
521 F VS ET ES R GS ES GI FT NTK ES SSH H
P G A E FPS R GK S S SY 
Sbl SK OFT SST SYN R GOS T FE SK SY KHA 
DE AG SE AO HE GT HST 
~o I K R G H A K s R P v B ~ 
Z G V N O N E E G F F S A JG H R P L D K K R E E A P 
S L R P A P P P S G G G 
41 YR ARP AK A A AT~ K KV ERK APO AG G CL
 HAO POL G V LC PT G C 
81 a LOE ALL O OE RP RN S VD EL N N NV EA V a(
S,T)S S S SQ FY HY L 
121 L K D L WOK R q K ~ V K D NE NV V NEY SSE 
LE k HQ LY I DE TV NS N 
161 PT NL RV LR S I LEN LR SK OK LES D 
VS A QM E Y CRT PCT VS 
201 C N P V VS GK EC EE I R KG GETS EH Y 
LIO PD S S V KP YR VY C 
241 D M HT ENG G WT V ON Ra D GS VO F GR KW
 OP Y K Q G F G NV AT NT 
281 D GK NYC G LPG E Y W LG ND K SOL. TR HG
 PT ELL I EM E OW KG 0 
321 KV KAH Y G G FT V q NE AN KY O I S V N KY 
R GT AGNA L MOGA SOL 
161 MG E NtR TH T I H NG HF F STY ORONO G W 
LT SD PR KOC SK ED G G 
4Ql G WW Y N RC HAAN P NG RY Y W G G ~YT WO 
MAK HGT O O G V V W H NW 
441 KG SW Y SM R K HS MK I RP FF P Q 0 
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4 0 I ll L G G A f: ~ A G O V f 
Figure 3. Amino-acid sequence of the three ch
ains of fibrinogen. 
( Henschen,1983 ). 
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lack of the fibrinopeptide region in the ~-chain and the long 
carboxy-terminal extension of the dl(-chain (Figure 2). 
The homologies between the '13- and ~-chains are greater 
than for either the (d- or ~-chain with the a(;-chain, indicating 
that the /3- and ~-chain divergence lS a more recent event. The 
fibrinogen chains from different species are remarkably similar; 
rat and human chains are 82% identical, bovine and human )3-chains 
84% identical. The ~-chain of the lamprey resembles all other 
g-chains in that it lacks the fibrinopeptide region and is also 
cross-linked by Factor X!II after polymerization. Lampreys 
diverged from other vertebrates about 450 million years ago, thus 
the. three chains of fibrinogen evolved long before this time. In 
vertebrate fibrinogen there are regions that have changed rapidly 
and regions which have been tightly conserved. Evolutionary 
stability within a molecule often indicates a high degree of 
functional significance. The most divergent regions of the 
fibrinogen molecule are the fibrinopeptides A and B (Doolittle 
and Blomback, 1964). Their only functional role is to mask the 
potential polymerization sites in the ~and ft-chains. By 
contrast the amino terminals of the E(- and J-chains revealed after 
removal of the fibrinopeptides are highly conserved, this region 
being essential for fibrin-monomer polymerization (Table I). 
There is also a great deal of variability in the interdomainal 
coiled-coils where exact amino acid residues are not necessary 
for the Gi(-helical coiling of the three chains around one another, 
as long as polar residues and non-polar residues occur in the 
correct register (Doolittle et al, 1978). Lamprey e(- J3- and i-
chains differ more from each other than the human chains. The 
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Table I: Amino acid sequences at the amino-termini of fibrin 

















Gly-Pro-Arg-Leu-? -Glx-Glx ••. 
Gly-His-Arg-Pro-Leu-Asp-Lys ••• 






lamprey Q(-chain contains large amount s of glycine, serine and 
threonine and unusually low amounts of lysine. Antibodies raised 
against mammalian fibrinogen (rat and humans) do not recognise 
lamprey fibrinogen (Doolittle et al, 1976). 
There is a great deal of homology between the carboxy-
terminal regions of the ~-chains of human and lamprey, the 
pattern being similar to that of human~ and d-chains (Strong et 
al., 1985). Conservation of the carboxy-terminal ~c hain 
sequence is not surprising in the light of the important 
functions of this region of the t-chain. These are, reciprocal 
cross-linking by Factor Xlll (Chen and Doolittle, 1971), calcium-
binding (Purves and Lindsey, 1978), staphylococcal clumping 
(Strong et al, 1982), platelet aggregation (Hawiger et al, 
1982), as well as this region being a primary contact site for 
polymerization (Olexa and Budzynski , 1981). At the cross-linking 
site of the i-chains of lamprey the acceptor glutamine and donor 
lysine are only 4 residues apart, but cross-linking does occur, 
with formation of i-d imers (Doolittle and Wooding, 1974; 
Murtaugh et al, 1974). 
G E G Q Q H H L G G A K Q A G D V Human . 
G H G G Q Q Q s K G N s R G D N Lamprey. 
(Sequence from Strong et al, 1975) . 
1.4 FIBRINOGEN TO FIBRIN CONVERSION 
1.4.1 Polymerization sites 
Four steps occur in the formation of fibrin (Hermans and 
McDonagh, 1982). 
1) Activation of fibrinogen by thrombin cleavage of 
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fibrinopeptide A from the amino-terminal end of the 
~c hain , followed by slower cleavage of fibrinopeptide B 
from the amino-terminal end of the )-chain resulting in 
the formation of fibrin-monomer . 
2) End to end polymerization of monomeric fibrin to long 
strands two molecules in diameter called protofibrils . 
3) Lateral association of protofibrils to form fibrin fibres . 
4) Covalent cross-linking of fibrin by activated Factor Xlll 
resulting in the formation of g-chain dimers and eE-chain 
cross-linked polymers. 
Step l results in the exposure of polymerization sites in the 
central E domain of the fibrinogen molecule. Cleavage of 
fibrinopeptide A by thrombin exposes the gly-pro-arg site 
followed by the slower removal of fibrinopeptide B exposing the 
gly-his-arg site. Olexa and Budzynski, (1980) have defined four 
polymerization sites involved in fibrin formation. Two sites 'A' 
and 'B' unmasked in the E- domain by the action of thrombin, and 
'a' located in the D-domain complementary to 'A'. A fourth 
polymerization site 'b' also located on the D-domain is formed by 
the alignment of the D-domain of two fibrin monomer molecules 
(Figure 4). 
Fragment D inhibits fibrin formation by binding to the 
protofibril via a portion of the same polymerization contacts 
that are used for attachment to another fibrin monomer (Hermans 
and McDonagh, 1982; Hantgan et al, 1983). The inhibitor action 
of fragment Dis due to the blocking of both ends of the growing 
protofibrils, each by a molecule of fragment D (Knoll et al,1984). 
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Thrombin 
Fibrinogen /" Fibrin monomer 
Linear fibrin polymer 
II 
Lateral fibrlh polymer 
Figure 4. Model for human fibrin polymerization. 
( Olexa and Budzynski,1983). 
Thrombin cleavage of fibrinopeptides A and B exposes two 
sets o f binding sites "AA" and "BB". The binding of 
"A" sites on the E-domain with complementary "a" 
sites on the D-domain results in linear polymerisation of 
molecules. This in turn gives rise to a bivalent 
"bb" site also in the D-domain complementar y to the 
"B" site in the E-domain. These sites allow for lateral 
aggregation of the fibrin strands. 
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The work of Heene and Mathias (1973) showed that fibrinogen will 
bind to fibrin-monomer covalently linked to sepharose. It was 
subsequently demonstrated that fragment D also binds to 
immobilized fibrin monomer, specifically t o the N terminal 
disulphide knot, supporting the theor y of complementary binding 
sites on the D-domain, (Kudryk et al. ,1974). The mode of 
alignment of the D-domains during polymerization is still not 
clear. Three kinds of contacts have been postulated, (Hermans 
and McDonagh , 1982) - these are:-
a) D E-staggered 
b) DD-long 
c) DD-lateral contacts 
The DE-staggered contact represents the contact between the D 
and E domains. The site in the E domain is exposed after 
cleavage of the fibrinopeptides. It has been shown that fragment 
D binds to E, (Olexa and Budzynski, 1979) and to the amino-
terminal disulphide knot (NDSK) of the E domain (Kudry k et al, 
1974). Inhibition of fibrin assembly by a synthetic peptide 
gly-pro-arg, (Laudano and Doolittle, 1978), the sequence of the 
~chain after cleavage of fibrinopeptide A, suggests that this 
part of the "=-chain participates in the D-E staggered contact. 
The tetrapeptide gly-his-arg-pro, which is the sequence of the 
N-terminal of the ~chain after removal of fibrinopeptide B, 
binds to fragment D. This site is thought to strengthen the DE-
staggered contact. (Laudano and Doolittle, 1981). The DD-long 
contact is formed between two D-domains that are adjacent to one 
another and results in an increase in length of the protofibrils. 
This contact site is strengthened by the cross-linking of the 
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~-chains of the two D-domains. The DD-lateral contacts are 
thought to be responsible for the formation of fibres from 
protofibrils (Fowler et al, 1981) (Figure 5). 
1.4.2 Transglutaminases 
The transglutaminases are a group of enzymes that catalyze a 
calcium dependent acyl transfer in which the t-carboxamide group 
of peptide bound glutamine residues are the acyl donors. Primary 
amino groups of a number of compounds including the £-amino group 
of peptide bound lysine residues function as acyl acceptors. The 
transglutaminases are found in tissues such as liver and 
epidermis as well as circulating in zymogen form in plasma (Folk 
and Finlayson, 1977). 
Following polymerization of fibrin-monomers, stabilization 
of the resulting clot occurs with the formation of c-(t-glutamyl) 
-lysine) cross-links between anti-parallel orientated i-chains of 
the D-domains of fibrin. This cross-linking reaction is 
catalyzed by a transglutaminase: glutamyl peptide glutamylyl 
tranferase or Factor Xlll (EC.2.3.2.13). The zymogen form in 
plasma is converted to the active enzyme Factor Xllla by 
thrombin. 
(FPA + FPB) 
fibrinogenn ~ ~ fibri~n 
~~-~ thrombin + Ca++ 
~~~~~-~•(fibrin) gel 
- n 
Factor XIII + ~~~~-•• Factor XIII a 
(Lorand,1983). 
~1 
cross-1 inked (fibrin) 
Thus the exposure of polymerization sites on fibrinogen is 




Figure 5. Schematic representation of fibrin polymerisation. 
( Hermans and McDonagh , 1982). 
a) fibrinogen molecule with central E-domain and two 
terminal D-domains. 
b) fibrin dimer showing DE-staggered contacts. 
c) fibrin trimer with DE-staggered and DD-long contacts. 
d) protofibril. 
e) formation of fibres 
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cross-linking of the g-chains 1s rapid, not easily inhibited and 
precedes G(-chain cross-linking. The t-chain cross-links result 
in the formation of covalent t-dimers. The a(-chain cross-linking 
can incorporate 5 or 6 chains to form a complex ~chain polymer 
(McDonagh et al, 1971). The region of the t-chain where cross-
linking occurs is highly conserved in all vertebrate species, 
permitting hybrid cross-linking of the i-chains of fibrin from 
different species eg. bovine-human (Chen and Doolittle, 1971). 
The finding of these hybrids also confirms the formation of 
intermolecular as opposed to intra-molecular cross-links. 
It has recently been demonstrated that a peptide gly-pro-
arg-pro that binds to the polymerization site in the D-domain of 
fibrin{ogen) {Laudano and Doolittle, 1981), modifies the 
glutamine cross-linking sites on both <aE,and g-chains of 
fibrinogen in such a way as to inhibit intermolecular cross-
linking by transglutaminase {Achyuthan et al, 1986). 
The formation of cross-links bestows a number of important 
qualities on the cross-linked protein: rigidity, strength, 
insolubility and stability. The last quality is a reflection of 
the resistance of the fibrin cross-link to proteolysis. Enzymes 
capable of separating the cross-linked D-domains of fibrin in the 
native state, at neutral pH and physiological concentrations of 
++ Ca , have not been reported. 
1 . 4.3 Assignment of the fibrin cross-link site in the i-chain . 
The cross-link site lies in the carboxy-terminal end of the 
~-chain. The acyl acceptor is lysine ~-406. One of two 
glutamine residues could be the putative acyl donor: glutamine 
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t-398 or t-399. Under natural conditions the carboxy-terminal 
peptide segments from adjacent i-chains are aligned anti-parallel 
and are reciprocally cross-linked by two E-{i-glutamyl)-lysine 
isopeptide bonds, the lysine side chain of one segment being 
condensed with ~-glutamine side chain of the other and vice 
versa. The cross-link has been assigned to sites lysine i-406 
and glutamine i-398 of reciprocal human gA-chains, seven residues 
apart {Chen and Doolittle, 1971; Sharp et al, 1972; Doolittle, 
1973). The cross-link was assigned by locating [
14c]-glycine 
ethyl ester substituted onto fibrin by transglutaminase {Chen and 
Doolittle, 1970). The assumption made was that this occurred at 
the natural d-chain cross-link site. Since the actual cross-link 
sites have not yet been demonstrated by direct sequencing of 
cross-linked /-chains, it is possible that both glutamines at 
sites 8-398 and t-399 could be the target for transglutaminase 
activity. The cross-link site has also been studied utilising a 
fluorescent lysine analogue - monodansyl-cadaverine - that is 
incorporated into the cross-link sites by transglutaminase. 
Digestion of this partially cross-linked fibrin by plasmin gives 
rise to a fluorescent D-dimer with an intact cross-link and 
dansyl-cadaverine substituted cross-link sites {Purves and 
Lindsey, 1978). 
D-dimer can be separated into monomers when the molecule is 
rendered susceptible to plasmin cleavage by removal of calcium 
ions. Under these conditions two smaller D-monomers with 
shortened t-chains, and a peptide containing the cross-link and 
the substituent fluorescent dansyl cadaverine, are produced 
{Haverkate and Timan, 1977; Purves and Lindsey, 1978). 
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1.4.4 Role of calcium in the clotting of fibrinogen and the 
structure of fibrin 
Calcium ions are required for all stages of the clotting 
-6 
process and fibrinogen itself binds calcium (Kd 8.7 x 10 M) . 
(Lindsey et al, 1978). Removal of Ca++ ions by chelation with 
EDTA renders fibrinogen more susceptible to thermal and alkali 
denaturation (Ly and Godal, 1973) and to further plasmin 
degradation beyond the natural terminal plasmin degradation 
products D-monomer, in the case of fibrinogen , and D-dimer in the 
case of fibrin (Haverkate and Timan, 1977; Purves and Lindsey, 
1978) Since calci um ions are always present in physiological 
fluids in vivo consequences of the removal of Ca++ ions would 
appear to be irrelevant in plasmin- mediated fibrinolysis and 
related phenomena. It has been demonstrated that fibrinogens 
from man (Purves & Lindsey 1978), rat (Niewenhuizen et al, 1981) 
and cow (Marguerie, 1977) have three calcium binding sites. Two 
of these high affinity sites (Kd 10.6 x 10- 6M) have been shown to 
be situated in each of the two D-domains (Purves et al, 1978; 
Haverkate and Timan, 1977; Niewenhuizen, 1979). 
Recently the calcium-binding site on the D-domain has been 
shown to be located in the peptide t-311 to t-336 using terbium 
fluorescence (Dang et al, 1985). The sequence of the t-chain 
peptide from i-315 to )(-329 is homologous to ~ther calcium 
binding proteins notably calmodulin (Henschen, 1983) and 
parvalbumin (Kretzinger, 1973). 
The third calcium-binding site (Kd 1.8 x 10- 4 M) is situated 
in the central E domain of fibrinogen, specifically in the NDSK 
portion of the E domain involving residues AG(.17-19, BJ 15-53 
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and/ or i-54-78 (Niewenhuizen et al, 1983). 
1.4.5 Binding of fibronectin, and plasminogen to the fibrin clot 
Fibrin clots are composed of fibrin, fibronectin (Mosher and 
Johnson, 1983) «.-2 anti~plasmin (Tamaka and Aoki, 1981) and 
plasminogen (Patthy and varadi, 1983). Fibronectin associates 
with the clot both by non-covalent binding and covalent cross-
linking mediated by activated Factor Xlll, with the ~-chain of 
fibrin. The 13(-chain of fibrin contributes the lysine donors 
w~ ile the fibronectin provides the glutamine acceptors for the 
formation of E-(t-glutamyl)-lysine cross-links. One of the 
functions of fibronectin association with the fibrin clot may be 
to form a surface for the attachment and spreading of cells 
during wound healing (Grinnell, et al, 1980). Plasminogen 
binds to both fibrinogen and fibrin but more strongly in the case 
of fibrin suggesting that the plasminogen binding sites are not 
fully fuctional in fibrinogen. (Lewis et al, 1984) have shown 
that one-mole of fibrinogen will bind 4 moles of either lys- or 
glu-plasminogen with a progressive increase in the affinity of 
plasminogen for fibrinogen as the binding sites are occupied, 
suggesting co-operative binding behaviour . There are binding 
sites for plasminogen in both the D and E domains of fibrin. 
Proteolytic modification of fragment D1 to DEDTA causes a
 
significant increase in a number of plasminogen binding sites 
suggesting that the carboxy-terrninal end of the i-chain may be 
involved in masking the plasminogen binding site in the D domain 
(Varadi and Patthy, 1983) . Fibrin appears to have at least two 
types of plasminogen binding sites, one on intact fibrin clots 
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and another on partially plasmin degraded clots. All the early 
cleavages by plasmin during fibrinolysis are at lysyl bonds thus 
creating new plasminogen binding sites (Bok and Mangfl, 1985). 
1.5 FIBRIN(OGEN)OLYSIS 
1 .5. 1 Plasmin degradation of fibrinogen 
The mechanism for fibrinogen degradation by plasmin in vitro 
has been extensively studied (Marder et al, 1969; Pizzo et al, 
1972, 1973a 1973b; Mosesson et al, 1973; Ferguson et al, 
1975). However the in vivo degradation of fibrinogen is not as 
well understood. Both fibrinogen and fibrin have an affinity for 
the lysine binding sites of plasminogen. This plasminogen 
binding anticipates the eventual dissolution of the fibrin clot. 
Fibrinogen binds plasminogen less strongly than fibrin (Lucas et 
al., 1983). The bound plasminogen is activated by tissue 
plasminogen activators related to urokinase and converted to an 
active plasmin (Niewenhuizen et al, 1983; Lucas et al, 1983; 
Silverstein et al, 1985). As plasmin begins to digest the 
fibrin clot, more plasminogen binding sites are exposed. Plasmin 
hydrolyses proteins and peptides at the carboxyl side of arginyl 
and lysyl residues in both protein and ester substrates 
(Wainstein and Doolittle, 1972). 
Plasmin digestion of fibrinogen proceeds _through 
asymmetrical cleavage of the fibrinogen molecule to fragment x, 
Y and ultimately the terminal degradation fragments D and E 
(Lucas et al, 1983). First step in fibrinogen degradation is 
removal of peptides+/- 40,000 M.W. from the carboxy-terminal end 
of the"'A-chain leaving an amino terminal remnant of ~A attached 
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by the disulphide bonds to bf and the )Cchains. This degradation 
is in fact difficult to prevent eg. in stored plasma. Plasmin 
then cleaves peptides 60,000 daltons from the amino-terminus of 
the ~b-chains (Mosesson et al, 1972; Budzynski et al, 1974) 
followed by splitting of the molecule by cleavage through all 
three chains with assymetric products produced en route. These 
susceptible cleavage sites occur where the regularity of the 
coiled-coils is perturbed by proline residues imparting a 
structure that determines sensitivity to plasmin. A single 
cleavage gives rise to fragment Y with release of one fragment D. 
Another similar cleavage reduces Y to a second fragment D and 
frees the central region of the molecule, fragment E, containing 
the amino terminals of the six chains held together by disulphide 
bonds i.e. the NDSK or N-terminal disulphide knot (Figure 6). It 
has been found that fragment D and E of plasmin digested 
fibrinogen form non-covalent complexes (Plow et al, 1977). 
However this association does not occur in native fibrinogen or 
between individual fibrinogen molecules. 
1.5.2 Plasmin degradation of fibrin. 
Fibrin is degraded by plasmin in the same way as fibrinogen 
in an orderly sequence of proteolytic cleavages. The clearest 
model of fibrinolysis has been proposed by Francis and Marder, 
(1982, 1983). Their proposed model is summarized as follows: 
1) Limited proteolysis, but all D and E domains still 
attached covalently to other parts of the clot matrix. 
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Figure 6. Diagram of fibrinogen digestion by plasmin. 
( Lucas et al 1983 ) • 
The small vertical arrows represent plasmic cleavages; 
the dashed lines indicate the minimal number of 
disulphide bonds present in each fragment. 
4 0 
3) Release of soluble complexes into solution . 
4) Degradation of soluble complexes to plasmin-resistant 
terminal forms D-dimer and fragment E, that are 
non-covalently associated (Olexa and Budzynski, 1979). 
Under physiological concentrations of calcium plasmin is 
unable to cleave D-dimer (Haverkate and Timan , 1977; Purves et 
al, 1978) . Francis and Marder (1982) by means of SDS-gel 
electrophoresis of fibrin digests, have characterised several 
soluble cross-linked fibrin degradation products: DD/ E, DY/YD 
YY/DXD and XXD/DXY. Following their release into solution 
furt her plasmin degradation results in fragment D-dimer and 
fragment E. Due to the intact polymerization sites of fragment 
D-dimer and fragment E, they have a high affinity for each other 
and tend to associate non-covalently (Olexa and Budzynski, 1979). 
Fragments D1 
and D-dimer have been shown to inhibit clot 
formation by blocking the polymerization sites on the E-domain of 
fibrin monomer (Hermans and McDonagh, 1982). 
41 
1.5.3 Physiological interactions of fibrin(ogen) degradation 
products 
At least five species of fragment D can be formed in vitro, 
each differing in the extent of the carboxy-terminal degradation 
of the ~-chains (Purves and Lindsey, 1978). Physiological 
++ 
concentrations of Ca protects fragment o1 from conversion to 
the other species (Haverkate and Timan, 1977; Purves et al, 
1978). Fragment o1 possesses
 the ~-chain cross-link site 
(Ferguson et al, 1975), a calcium binding site (Purves et al, 
1978), a binding site for the platelet receptor for fibrinogen 
(Kloczewiak et al, 1982) and a staphylococcal binding site 
(Hawiger et al, 1982). 
Clumping of staphylococci by fibrinogen is an example of a 
cell agglutination reaction which requires that the agglutinin 
i.e. fibrinogen, be bivalent in order to effect the binding of two 
cells together. This requirement is fulfilled as the 
staphylococcal binding site is in the D-domain, and there are two 
D-domains in the fibrinogen molecule. The breakdown of the 
bivalent fibrinogen molecule into two monovalent fragments D 
abolishes the clumping reaction but retains the ability to bind 
staphylococci (Hawiger et al, 1982). Fragment D stimulates 
fibrinogen synthesis (Ke~sler and Bell, 1980; Franks et al, 
1981) and the proliferation of haemapoietic ceJls in vitro 
(Hatzfeld et al, 1982). Intravenous infusion of purified 
fragment D1 
induces hypoxemia and tachypnea and increases 
capillary permeability in rabbits (Luterman et al, 1977). The 
plasma level of fragment Dis elevated in patients with the adult 
respiratory distress syndrome (Rinaldo and Rogers , 1982) and in 
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patients with disseminated intravascular coagulopathy {Bell, 





were found to disrupt 
endothelial cell monolayers in a dose responsive manner, 
indicating that fragment o directly disorganizes the architecture 
of the endothelial cell monolayer. Fragment D-dimer has the same 
effect. That the cross-link site is not necessary for this 
phenomenon is also shown by the effectiveness of D2 whic h lacks 
the cross-link site. These results suggest that fragment D plays 
a role in the pathogenesis of syndromes with vascular endothelial 





• Fragment D has been shown to inhibit clotting 
in fibrinogen solutions {Kawaski, 1968), to prolong thrombin 
clotting times {Belitzer et al, 1975), to decrease the rigidity 
and alter the light scattering of fibrin gels {Williams, 1981). 
Fragment D1 do
es not inhibit thrombin itself or the formation of 
fibres from protofibrils of sufficient length {Williams, 1981). 
Fragment D
1 
does inhibit fibrin assembly {Williams, 1981) and 
fibrin polymerization {Hermans and McDonagh, 1982). 
The region of the D-domain involved in staphylococcal 
clumping and platelet aggregation has been located in the 
carboxy-terminal region of the t-chain by means of inhibition 
studies using a 27 residue cyanogen-bromide fragment of the 
carboxy-terminal end of the 1(-chain. (Strong, 1982; Kloczewiak 
et al, 1982, 1984), have located the interaction of the D-domain 
of fibrinogen with platelets, in the last 15 residues from the 
carboxy-terminal end of the t-chain. varadi and Scheraga (1986) 
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using isolated fragment n
2 
which lacks carboxy terminal t-356-
411, have shown that this fragment binds calcium, but does not 
inhi bit polymerization. Thus the calcium binding site 9-311 to 
t-33 3 does not overlap with the polymerization site in the 
D-domain. However the binding of the calcium may cause 
conformational changes that enhance reactivity of the adjacent 
polymerization site. Horwitz et al, (1984) have localized the 
fibrin g-chain polymerization site within segment Thr-374 to 
Glu-396 of fibrinogen (Figure 7). 
1.5.4 Regulation of fibrinogen synthesis 
The main site of fibrinogen synthesis is the liver. 
Fibrinogen levels in plasma are closely correlated to 
physiological demands eg. in pregnancy, response to injury and 
bleeding and as an acute phase reaction in inflammator y states. 
Most work has shown that sharp reductions or elevations of plasma 
fibrinogen concentration do not influence the basal rate of 
fibrinogen synthesis (Alving et al, 1979). The most potent 
stimulator of fibrinogen synthesis in the intact animal was found 
to be fibrinogen fragment n
1
• In contrast fibrin degradataion 
products, cross-linked or non-cross-linked, had no stimulatory 
effect on fibrinogen synthesis (Kessler and Bell, 1980; Franks 
et al, 1981). The reasons why degradation products from 
fibrinogen but not from fibrin, stimulate fibrinogen synthesis, 
remain unexplained. Ritchie et al (1982} using rat hepatocyte 
monolayer cultures, found that fragment n1 stimulates fibrinogen 
synthesis through an indirect pathway involving cells of the 
reticuloendothelial system. When leucocytes were treated with 
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300 321 335 
SD K FF TS H NG M Q F ST W D ND ND K F E G NC A E Q D G G WM N KC HAG 
Ca I c i u m b i n d i n g (a 
3 74 
H L N GV YYOGGT YS KAST PN GY D NG HATKTRW YSMKKTT MKI IPF 
fibrin polymerisation {b 
398399 406 411 
N R LT I GE G Q Q H H LG GA K QA G DV 
cell agglutination (c 
platelet binding (d 
cross-linking (e 
Figure 7. sequence of the carboxy-terminal end of the 
~-chain of human fibrinogen showing regions 
important for specific activities. 
Information was compiled from the following references: 
a) Dang, 1985 
b) Olexa and Budzynski, 1980 
c) Hawiger, 1982 
d) Kloczewiak et al, 1984 
e) Chen and Doolittle, 1971. 
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fragments o1 a
nd/or E they responded by producing an hepatocyte 
stimulating factor (HSF) that had a dramatic effect on fibrinogen 
synthesis. Addition of fibrinogen itself to the leucocytes did 
not stimulate production of HSF. 
1.5.5 Synthesis of fibrinogen 
Comparison of the amino acid sequences of the three chains 
of fibrinogen shows that the three chains are highly homologous 
and suggest that they arose from a common ancestral gene 
(Doolittle et al, 1979). Since all vertebrate fibrinogen 
including lamprey fibrinogen is made up of the three chains 
triplication of the gene must have occured more than 450 million 
years ago, making fibrinogen a very ancient multi-chain protein 
(Crabtree et al, 1985). Recent work has shown that eac h chain 
has an independent messenger-RNA indicating the presence of three 
genes (Nickerson and Fuller 1981; Crabtree and Kant 1981; Rixon 
et al, 1983; Kant et al, 1983). The work of Kant et al (1983) 
has confirmed the postulate that the genes for the three 
polypeptide chains have arisen by duplication and subsequent 
divergence of an ancestral gene. Thee( and !3-genes arose first 
with subsequent splitting at a later stage of the beta and gamma 
genes. 
Kant et al (1985) have shown that the genes encoding the ta(-, 
,- and x-chain polypeptides of human fibrinogen occur as single 
cop ies closely linked in a 50 Kb region of chromosome 4. The«-
gene lies between the t- and)3-genes. The «and i-gene are 
oriented in tandem and transcribed towards the /3-gene. The ft-
gene is transcribed from the opposite DNA strand toward the r- and 
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«-genes. The structure of the x-gene is closely related to the 
functional regions of the j-chain. The human i-chain gene 
consists of 10 exons coding for the 411 amino acid residues and a 
leader sequence of 26 amino-acids (Rixon et al, 1985). The 
positions of the nine introns divide the gene into 10 segments 
each roughly corresponding to separate functions in the ~-chain. 
Exon I codes for the signal peptide and Exon II for the cysteines 
forming the disulphide bridge linking the i-chains together. 
Exon III codes for the cysteines of the first disulphide ring and 
a portion of the coiled-coil, and the carbohydrate attachment 
site at asparagine residue 52. Exon IV codes for more of the 
coiled-coil and exon v the rest of the coiled-coil and the second 
disulphide ring marking the end of the coiled-coil. The residues 
found in the D-domain are coded for by exons VI, VII and VIII. 
This region shows the highest degree of homology when compared to 
the ~-chain are between j-chains of different species. Exons IX 
and X code for the region containing the cross-linking amino acid 
residues as well as those residues involved in fibrin 
polymerization and platelet receptor recognition. The last intron 
contains sequences that code for the i-chain extension and is 
generated by alternative processing and polyadenylation of the 
i-chain transcript within the IXth intron resulting in read-through 
of the 9th intron/exon functional sequence (Rixon et al, 1985). 
The mRNAs for the three genes are co-ordinately regulated at 
the transcription level (Fowlkes et al, 1984). Although there 
is only one gene for the "t-chain of fibrinogen, two i-chains are 
synthesized gA and jB, differing only in their carboxy-terminal 
ends (Wolfenstein-Todel and Mosesson, 1984). Crabtree and Kant 
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(1982) propose an alternative pathway of splicing mRNA 
transcripts as a likely mechanism for the production of jB in 
rat s. 
Fornace et al (1984) have found that there is only one locus 
for the i-gene and that iA and ~B arise by alternate mRNA 
splicing near the 3' end of the gene . In the rat jB is produced 
by alternate splicing with identical polyadenylation sites 
{Crabtree and Kant, 1982). In humans jB is produced when the 
VIIIth intervening sequence remains unspliced and a 
polyadenylation signal within this intron is used. The new 
car boxy-terminus of the iB-chain is 16 amino acids longer than 
the ~A-chain. The two j-chains are produced at the same time in 
the liver, and their relative proportions remain the same even 
after subjecting the liver to a variety o f stimuli known to 
induce fibrinogen messenger-RNA (Crabtree and Kant, 1982). 
In vitro studies have indicated that the individual chains 
are assembled in the rough endoplasmic reticulum into the dimeric 
molecule {Kudryk et al, 1982). Fibrinogen assembly commences 
while riascent PB-chains are still attached to membrane-bound 
polysomes, followed by the nearly simultaneous incorporation of 
A« and j-chains {Alving et al, 1982) from the intra-cellular 
pool of these chains {Yu et al, 1983). 
In humans and rodents fibrinogens of slightly different 
molecular weights are synthesised due to the existence of two 
~-c hains - iA and iB· 
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1 . 6 ASSAY OF FIBRINOGEN / FIBRIN DEGRADATION PRODUCTS 
The immunological approach to the study of fibrinogen and 
its derivatives has assummed increasing importance. Current 
fibrinogen degradation product (FDP) assays are unreliable. The 
difficulties of accurate FDP assay are three-fold: 
i) The specificity of the antibody in immunological assays 
ii) The generation of fibrin degradation products during 
handling of the blood samples 
iii) The loss of fibrin fragments generated in vitro and the 
development o f soluble fibrin related to the processing 
of the sample in thrombin induced sera. 
The conventional FDP assays give little real information 
about in vivo levels in patients (Gaffney and Perry, 1985). Any 
immunological method for detection of FDP's in vivo, must be able 
to distinguish between Y-D, (Y-D) X-L(D-Y) as well as X, Y, D, 
D-dimer and E. 
The advent of monoclonal antibody tec hniques has facilitated 
the development of antibody probes wit h affinit y for specific 
epitopes. In the review by Plow and Edgington (1982), roughly 
thirty-five epitope sets present in fibrinogen and its 
derivatives are described. They point out that large regions of 
the molecule remain unexplored. These include the central 
portion of the ~-chain, the at-chain extension that lies outside 
the D-domain, the i-chain that lies between the D and E domains 
that contains several plasmin cleavage sites, and the carboxy-
terminal end between residues i-265 and i-411 which contains a 
number of physiologically important sites. There are two main 
types of epitope - simple epitopes where antibodies will bind 
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denatured polypeptide chains or limited peptide sequences 
contained within the epitope - and - comple x epitopes that 
require a specific conformation o f th e polypep tide chains and 
often consist of non-sequential elements of th e sequence of one 
or more peptide c ha ins. 
several assay systems have been developed wit h a high degree 
of sensitivity for specific fibrinogen antigens at low 
concentrations in plasma. These include radio-immunoassays and 
enzyme linked immunoassays (ELISA), both using monoclonal 
antibodies. The epitopes used for the raising of monoclonal 
antibodies include whole fibrinogen which resulted in antibodies 
that bind D-monomer and f ragment D obtained from non-crosslinked 





thus indicating that the epitope lies in the carboxy-terminal end 
of the i-chain (Wilner et al, 1982). 
Monoclona l antibodies have been raised to the N-terminal end 
of the ~-chain of fibrin that are able to distinguish between 
fibrinogen and fibrin and fragment E derived from these two 
molecules (Hui et al, 1983). Their method has been developed 
further resulting in the production of a species specific 
antibody, using a sequential epitope, the human post-thrombin 
amino-terminal sequence, peptide ft(l-7) -
gly-his-arg-pro-leu-asp-lys-
that binds to human and canine fibrins but not bovine, ovine 
or porcine fibrins (Matsueda and Margolies, 1986). 
Muller-Berghaus et al (1985) have developed a monoclonal 
antibody directed at the amino terminal end of the te(-chain after 
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cleavage of fibrinopeptide A, exposing the sequence -
gly-pro-arg-val-val-glu-. 
This antibody raised with the hexapeptide as antigen, is able to 
distinguish between fibrin and fibrinogen. Rylatt et al (1983) 
have developed a solid phase enzyme linked radio-immune-assay 
with a sensitivity of 10 ng /ml, suitable for detection of cross-
linked derivatives in serum and plasma samples in a clinical 
situation (Hafter et al,1985). One of the aims of the present 
study is the utilization of puffadder venom enzyme to expose 
further epitopes in the i-chain of cross-linked D-dimer. 
1.7 SNAKE VENOMS AND FIBRINOLYSIS 
1.7.1 Proteinases from snake venoms 
Snake venoms are a prolific source of enzymes many of which 
are useful in coagulation studies. At least 26 enzymes types have 
been described, 10 of which are found to be common to all snake 
venoms, and the other sixteen are scattered throughout the five 
families of poisonous snakes (Russel, 1980). These enzymes tend 
to be chacteristic of certain families or genera eg. elapid 
venoms are rich in acetyl cholinesterase whereas crotalid and 
viperid venoms lack this enzyme but are rich in endopeptidases 
(Table II). 
Many of these enzymes interfere with blood coagulation (Dyr, 
1983; Niewerowski, 1979; Ouyang, 1979) and have extensively 
studied due to their potential clinical importance. These 
enzymes affecting coagulation may be devided into two groups; 
those with thrombolytic activity eg. ancrod and batroxabin (Dyr, 
1983; Kirby, 1979; Bajwa, · 1982), and those with 
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Table II: Enzyme distribution in various snake venoms. 
Snake venoms (crude) 
Crotalidae 
Agkistrodon halys blomhoffii 
A. piscivorus piscivorus 
A. contortrix contortrix 




c. durissus terrificus 
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Protein activity expressed as ug of tyrosine equivalent of TCA-
soluble product formed per minute per mg protein. 
Arginine hydrolase activity expressed as umoles of 
a-toluene sulphonyl ethyl ester hydrolysed per minute per mg 
protein. 
++=fibrin fibres appear in 3 min.,+= within 20 min., 
+=within 2 hours. 
Iwanaga et al,1976. 
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fibrin(ogen)olytic activity; (Moran and Geren, 1981; Bajwa and 
Pandya, 1984) . The fibrinolytically active enzymes may be 
further grouped according to which chain of fibrinogen they 
preferentially attack, namely the Q;'.an d f-fibrinogenases 
(EC 3.4 . 21 . 5) (Ouyang, Feng and Chen, 1977; Teng, Ouyang and 
Lin, 1985; Nikai et al, 1983). The @(-chain o f fi b rinogen is 
very susceptible to proteolytic attack and many o f the snake 
proteases disrupt it eg . ecarin from Echis carinatus, which 
digests the Cll(-chain of fibrinogen rendering it incoaguable by 
preventing cross-linking of the at-c h ain (Kornalik, 1979 ) . Venom 
from Naja nigricollis contains an enzyme t hat degrades only the 
a,(-c hain of fibrinogen and the ~-polymer from fibrin leaving the 
fi- and t-chains intact (Evans, 19 81). Pandja and Budzynski 
(1984) have isolated four enzymes from Crotalus atrox, two of 
which were found to be alkaline serine proteases wh ic h only 
attack the fi-chain of fibrinogen and two wh ic h are zinc ion 
dependent metalloproteinases. 
1.7.2 Puffadder (Bitis arietans) venom proteases 
The venom of the puffadder acts slowly by destroying tissue 
and haemolyzing the blood through the action of proteases unlike 
the fast acting fatal neurotoxic venom of the cobras. Van der 
Walt (1971) separated three major and two minor proteases by 
gradient elution from CM-cellulose. One of these proteases -
protease A was further purified by Sephadex G 75 gel filtration. 
The enzyme MW 21,400 hydrolysed casein with a pH optimum of 10. 
The enzyme was inhibited by EDTA but not inhibited by DFP, 
mercuric compounds, or chloromethylketones. The protease did not 
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hydrolyse TAME or ATEE. It was found to have a broad specificity 
with three different protein substrates hydrolysed randomly 
yielding a large number of small peptides. Synthetic peptides 
such as met-phe-gly , gly-leu-tyr, gly-leu, gly-ile and poly-L-tyr 
were not attacked by protease A, suggesting that it requires a 
substrate exceeding a certain minimum number of amino acids (Van 
der Walt, 1970). He concluded that a hydrophilic region 
stretching over two residues as well as an hydrophobic residue in 
the substrate polypeptide chain promote the affinity of protease 
A for that region and are desirabl e for the hydrolysis of the 
peptide bond in that region. Iwanaga (1976) has stated that 
proteinases from a number of snake venoms (Table II) hydrolyse 
many kinds of substrates with a specificity that is directed 
toward bonds in which the amino groups are contributed by 
hydrophobic residues (Iwanaga, s., Oshima, G. T., Suzuki, T.). 
In all cases studied specificity is dictated by the identity of 
the residue contributing the amino group to the bond, and 
preference is for a hydrophobic residue in this position. There 
is also a minimal substrate size for hydrolysis. 
several workers have found that puffadder venom is the most 
potent of the snake venoms tested, preferentially destroying 
proteinase inhibitors in human plasma (Kress and Paroski, 1978; 
Kress, 1979). The enzyme or enzymes that are zinc ion dependent 
metalloproteinases destroy the serine protease inhibitors present 
in plasma thus rendering other enzymes eg. renin (La'{irence and 
Morris, 1981) and prekallikrein active (Morris et al, 1980). 
The effects of puffadder venom on fibrinogen and fibrin have not 
been studied. 
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An haemorrhagic principle was isolated from puffadder that 
had no caseinolytic or esterase activity and was not associated 
wit h th e lethal properties of the venom {Meb s and Panholze r, 
1982). Zinc dependent metalloproteinases with low molecular 
weight 21,000-24,000 daltons have been isolated f rom many snakes 
{Ou yang et al, 1979; Evans, 1981; Dyr et al, 1983; Pandya et 
al, 1983; Pandya and Budzynski, 1984). They have all been 
tested for activit y against fibrinogen, but only venom from 
Naja nigricollis was tested for fibrinolytic activity. This 
enzyme cleaved the Ga(-polymer but not the di -i-chain of fibrin 
(Evans, 1981). The low molecular weight, zinc-dependent 
metalloproteinase from puffadder venom has the ability to cleave 
D-dimer, from cross-linked fibrin, into two apparently 
symmetrical monomers (Purves et al, 1986). 
The aim of this study was to utilize the properties of this 
enzyme from puffadder venom to try and distinguish between any 
special conformational features of the D-domain s from fibrinogen 
and fibrin. Since the enzyme cleaved D-dimer into monomers it 
was necessary to establish whether the enzyme is an isopeptidase 




2 . 1 ASSAY METHODS . 
2 . 1.1 Polyacrylamide gel electrophoresis (SDS-PAGE). 
(a) SDS-PAGE - 1 . 5 x 150 x 150 mm slab polyacrylamide gels 
containing 1 % sodium dodecyl sulphate (SDS) were run at 50 V for 
16 hours in a Hoefer Model SE 60 0 electrophoresis apparatus. The 
acrylamid e gradients used were 4-20 %, 6- 8% and 10-12 %. Gels were 
stained wit h Coomassie Blue or silver stained if greater 
sensitivity was required. 
(b) Acid- Urea PAGE. 
Acid urea gels were run in the same Hoefer apparatus as the 
SDS gels . The tank buffer was 0 . 9 M acetic acid. The separating 
gel was 8 % acrylamid e containing 2 . 5M urea and 5 % acetic acid . 
The sample solven t was 0.1 M HCl containing 8 M urea, 5% BME and 
0 . 5 % pyronin Y. 
2 . 1.2 Protein Concentration . 
Protein concentrations were determined using a method based 
on the Bradford dye-binding procedure (Bradford, M. , 1976) . The 
dye Coomassie Blue G 250 was obtained from Biorad laboratories . A 
standard curve was constructed using bovine serum albumin from 0 
- 100 ~g in 0.1 ml; 0.5 ml of 5X diluted dye reagent added to an 
0 . 1 ml aliquot of 1 / 10 or 1/100 diluted sample . The blank was 
0 . 1 ml of distilled water or the buffer diluent . Urea , Tris and 
EDTA do not interfere with the assay . 
2 . 1.3 Chromozym assays l Lottenberg et al, 1981 l..!_ 
Activity of the plasmin used was ascertained using the 
Chromozym assay with Chromozym PL as substrate . 
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Substrate: Chromozym PL(Boehringer)-tosyl-glycyl-prolyl-lysine-
4-nitroanilide acetate M.W. 634,7. The substrate (20 mg) was 
dissolved in l ml distilled water adjusted to pH 4.0 with HCl and 
stored frozen. 
Assay buffer 0.01 M Hepes 
Assay 
0.01 M Tris/ HCl pH 7.8 
0.1 M NaCl 
0.1 % Polyethylene glycol 6000. 
l ml buffer 
0.1 ml substrate 
10 pl plasmin/ glycerol 
The reaction was followed in a spectrophotometer at wavelength 
405 nm. 
Assays were performed to ascertain the specificity of crude 
puffadder venom with four different Chromozym substrates. 
2.1.4 Fibrinogenolytic activity of puffadder venom protease. 
Fibrinogenase activity was measured by the method of Ouyang 
and Teng (1976). Fibrinogen solution, 5 mg (10 mg/ml) was 
incubated at 37°c with 50 µl of puffadder venom (1 mg/ml). At 
each time interval a 0.5 ml aliquot was withdrawn, thrombin and 
calcium added and the time noted for the clot to develop. 
Aliquots, 50 pl, were withdrawn at the same time interYals and 
analyzed on a 4-20% SDS-PAGE gel under reducing and non-reducing 
conditions and stained with Coomassie Blue. 
2 . 1.5 Caseinolytic assay for puffadder venom proteases. 
Substrate 1% casein was made by dissolving 100 mg casein with 
heating in 5 ml of 0.012 N NaOH and made up to 10 ml with 0.1 M 
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Tris/HCL buffer pH 9.0. 
Assay 100 }ll casein 
5 0 µl puffadder venom enzyme 
1 0 µ l 1 0 mM Zn C 1 
2 
The mixture was incubated at 37°c for thirty minutes, after which 
500 }ll of 0 .44 M trichloracetic acid was added. The solution was 
left at 4°c overnight and centrifuged. To 250 pl supernatant, 




, and 25 0 pl Folin-Ciocalteau reagent, was 
added, allowed to stand for 10 minutes and the absorbance read at 
66 0 nm. 
2 . 1.6 Monoclonal antibody radio isotope assay. 
The monoclonal antibodies for this work were a gift from Dr. P. G. 
Bundesen MAbCO. Inc. , Australia. 
"Soft" chloramine T iodination method (Walters, M. University of 
Queensland). 
Reagents: 1) Mix equal volumes of 0.3 M Na
2





to give phosphate buffer pH 7. 
2) 56 mg Chloramine Tin 10 ml H
2
0 diluted l in 100 
with 0.3 M Phosphate buffer. 10 pl of chloromine T 
solution per 990 pl H
2
0. 
3) 38 mg Sodium metabisulphite in 10 ml H
2
0 diluted 
l in 100 with 0.3 M sodium phosphate buffer. 10 µl 
metabisulphite per 990 pl H
2
0. 
4) Phosphate buffered saline (PBS) 
5) 2% bovine serum albumin (BSA) 





Mix: 25 µl 0.3 M sodium phosphate buffer 
25 µl 200 fg/ml protein or antibody in sodium phosphate 
buffer. 
1 0 µl Na 125r (1 mCi) 
25 µl chloramine T. 
Leave for 30 seconds 
Add 25 µl Na metabisulphite and 
1 drop of KI 
Dilute the reaction mixture with 50 0 pl PB S and two drops 2 % BSA. 
Recover iodinated protein by gel filtration on a Sephadex G 25 
PD-10 column equilibrated with 15 ml of PBS. Collect 10 0 .5 ml 
fractions. Count 1 0 l of each fraction. Pool the fractions with 
the highest counts, usually tubes 5, 6, and 7. 
In a capture/tag assay , the antigen in question is reacted with 
two antibodies with specificity for different regions of the same 
molecule. Usually a capture antibody is attached onto a solid 
phase and after addition of antigen to allow binding to occur, 
the presence of bound antigen can be detected after washing, by 
the addition of the second labelled antibody, labelled either 
wit h horse-radish peroxidase or with 125r. 
Radioisotope assay for cross-linked fibrin derivatives. 
Reagents: 
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1) DD - 3B6/22 Stored at 4°c. Diluted immediately before use. 














2 mg/ml in 50% glycerol. Store at -20 c. 
Store at 4°c. Dilute for tagging immediately 
before use. Diluted solution 1-2 x 10
6 cpm/ml. 
The wells of a 96 well U- bottomed polyvinyl-chloride microtitre 
plate (Dynatech Cat. No. 1. 220. 24) were coated by adding 50 pl 
of a 1/500 dilution (~ 10 pg/ml) of capture antibody DD-3B6/22 in 
phosphate buffered saline for 1 hour at room temperature. Unbound 
antibody was removed by inversion and tapping the plate followed 
by washing three times with PBS containing 0 .05 % Tween. Pour 
buffer to completely cover plate, leave 1 minute, invert and 
flick. Antigen capture was achieved by adding 50 pl of 0 - l 
pg/ml D-dimer standard, or 1/5 dilution of plasma or serum or 
test solution in PBS/Tween for l hour at room temperature 
(Fi gure 9). Remove unbound capture antigen and wash three times 
as before. The bottom of each well is cut off into a suitable 
counting tube, and counted in a gamma counter. 
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2 . 1.7 Dimertest agglutination assay. 
Agglutination test for the detection of cross-linked fibrin 
derivatives. Monoclonal antibody DD 3B6 / 22 coupled to latex beads 
obtained from MAbCO, P.O. Box 475, Springwood Queensland 4127, 
Australia. 
Buffer salts and standard were reconstituted as directed. 
Method 
1) Shake beads before use. 
Using pipette supplied place 0 .025 ml beads o n a clean slide. 
Add 0 .0 1 ml sample and mix. 
2) Rock slide gently. Read test after 3 minutes. 
3) Add 0.02 ml standard to 0.025 ml latex beads as a positive 
control. 
Estimation Sample dilution 
neat 1/2 1/4 1/8 
range ng /ml 1-200 
201-500 + 
501-1000 + + 
1001-2000 + + + 
>2001 + + + + 
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2.1.8 Fluorimetry 
The fluorescence spectra of f-D-monomer and f - D-d imer (dansyl 
fluorophore) were scanned in an Aminco SPF500 spectrofluorimeter. 
The optimum excitation wavelength was 34 0 nm and the emission 
wavelength 520 nm. 
Puffadder venom protease activity was measured using f-D-dimer 
as substrate by following the change in fluorescence. 
Assay. l ml of f-D-d imer (1 mg / ml) in Tr is/ HCl buffer pH 8. 0 
containing 150 mM NaCl, lmM cacl
2 
and l mM zncl
2
• 
100 pl of crude or purified puffadder venom (100 fg / ml). 
2.1.9 Preparation of plasmin. 
Plasminogen, 10 mg (Sigma) was dissolved in 2 ml of 0. 1 M 
Tris/HCl pH 7 . 4, 150 mM NaCl buffer and 500 units of urokinase 
added. The solution was incubated at room temperature for l hour 
and an equal volume of glycerol added resulting in a plasmin 
solution containing 2.5 mg/ml. Activity of the plasmin was 
checked using Chromozym PL (Boehringer) as substrate. The 
plasmin/glycerol solution was stored at -20°c. 
2.1.10. Definition of PAV protease activity with f-D-dimer as 
substrate. 
All assays were carried out for two hours at 37°c. 





Assay. 50 pl f-D-dimer (1 mg/ml in buffer) 
50 pl PAV protease (10 pg/ml) 
Digestions were terminated by the addition of an equal volume 
(100 pl) of SDS sample buffer containing EDTA with and without 
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,6-mercaptoethanol and analyzed on SDS-PAGE. 
2.2 PREPARATION OF FIBRINOGEN, FIBRIN AND PLASMIN DERIVATIVES 
2.2.1. Preparation of fibrinogen. 
Fibrinogen was prepared by repeated ammonium sulphate 
precipitation of citrated human plasma. The final precipitate was 
dissolved in 5 mM trisodium citrate and dialysed against 50 mM 
Tris/HCl buffer pH 7.4 with 150 mM NaCl. 
Rat and hagfish fibrinogen were prepared using this method. 
The fibrinogen/fibrin plasmin derivatives were prepared from 
fibrinogen obtained from Sigma. 
2.2.2. Preparation.£! fluorescent D-dimer and fluorescent 
D-monomer (Purves and Lindsey, 1980). 
Dansyl cadaverine (Sigma) is a lysine analogue that inhibits 
cross-linking of the i-chains. At a concentration of 2.45 mM 
only some of the cross-links are inhibited resulting in fibrin 
wit h fluorescently labelled i-chains (Purves and Lindsey, 1980) . 
Some of the cross- links sites are completely inhibited resulting 
in f -D-monomer that appeared to be identical to non- fluorescent 
D- monomer from digestion of fibrinogen by plasmin . Thus 
f-D-monomer was always found in f-D-dimer preparations . 
Fibrinogen, lg (Sigma) was dissolved in 100 ml of 0.1 M Tris/HCl 
pH 7.4 buffer containing 150 mM NaCl . Dansyl cadaverine, 80 mg 
(2.45 mM) was dissolved in a small volume of 6 N HCl and the pH 
neutralized with 6 N NaOH taking care to keep the dansyl 
cadaverine in solution. The solution was made up to 5 ml with 0.1 
ml Tris/HCl buffer pH 7.4 containing 100 mM cacl 2 
100 u of 
thrombin and 2 mg Factor Xlll . This entire solution was added 
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to the dissolved fibrinogen and the mixture incubated at 37°c 
overnight. The clot was placed between sheets of filter paper and 
pressed flat. The clot was resuspended in 50 ml 0 . 1 M Tris/HCl 
buffer pH 7.4 containing 150 mM NaCl and 10 mM cacl 2 and 1.0 ml 
(2.5 mg) plasmin added. The suspension was incubated at 37°c 
overnight, by which time the fibrin clots were totally digested. 
The solution containing fluorescent D-dimer and fragment E, was 
dialyzed against 5 mM Tris/HCl pH 8.6, 1 mM cacl
2 
filtered, and 
loaded onto a DEAE-52 cellulose (Whatman) column (20 x 2 cm) 
washed with starting buffer and eluted with a salt gradient 
0-0.3 M NaCl . The fractions were analysed by PAGE-electrophoresis. 
Pools were made of the fractions containing f-D-dimer, and 
f - D-monomer. These were concentrated by ultrafiltration using 
Millipore submersible CX-10 units,prior to gel filtration of the 
fragments. 
2.2.3. Gel filtration of the pooled concentrated fractions 
from DEAE anion exchange chromatography 
The concentrated pools of fractions containing f-D-monomer and 
f-D-dimer were molecular sieved on a column of Ultrogel AcA 34 
(100 x 2 cm) equlibrated with 0.1 M Tris/HCl buffer pH 7.4 
containing l mM cacl
2 
and 4 M urea. Flow rate 30 ml/hour, 
fraction volume, 3ml. Aliquots of the fractions were analyzed by 
means of SDS-PAGE, and fluorescent fragments located with u.v. 
light prior to staining of the gel with Coomassie Blue. Fractions 
containing f-D-monorner and f-D-dimer were pooled, concentrated 
and stored at -20°c. Protein concentration was ascertained using 
the Biorad Coomassie Blue dye-binding method. 
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2.2.4 Preparation of non-fluorescent D-dimer . 
Non-fluorescent fragment D-dimer was isolated from a plasmin 
digest of fibrin clotted in the absence of dansyl cadaverine, 
using the same methods as for the isolation of f-D-dimer . 
2.2.5 Preparation of D-monomer (non-fluorescent) . 
Fibrinogen, lg (Sigma) was dissolved in 100 ml of 0.1 M Tris/H Cl 
buffer pH 7 .4 containing 150 mM Nacl, 50 0 pl of plasmin solution 
(2.5 mg/ml) was added and the mixture incubated at 37°c . After 
ten minutes incubation calcium was added to give a final 
concentration of 5 mM, and the solution incubated overnight at 
37°c. The digestion was terminated by addition of Trasylol (1000 
U/ml) and dialysed against 5 mM Tris/HCl buffer pH 8 .6 containing 
l mM cacl
2
. After dialysis the solution was passed through an 
0 .4 5 y Millipore filter. The solution was chromatographed on 
cellulose DE-52 (Whatman) column to separate D-monomer from 
fragment E (Nussenzweig et al, 1961). The fractions were 
collected on an LKB fraction collector flow rate 50 ml/hour, 
fraction volume 5 . 0 ml and the D-monomer located by SDS-PAGE 
electrophoresis. The fractions containing D-monomer were pooled, 
concentrated by ultrafiltration using a Millipore immersible 
CX-10 ultra-filtration unit and stored frozen. Fluorescent 
D-rnonomer was obtained as a by-product during preparation of 
fluorescent D-dirner due to incomplete cross-linking on addition 
of 2.45 rnM dansyl-cadaverine, the yield being determined by the 
amount of dansyl-cadaverine present (Purves et al, 1980). 
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2.2.6. Preparation of D-PAV-monorner. 
Fluorescent or non-fluorescent D-dirner was incubated at 37°c for 
1 8 hours with purified puffadder venom protease (PAV) in 0 .1 M 




. Enzyme to substrate ratio was 10:1. Cleavage of the 
D-dirner to D-PAV-monorner was checked by means of SOS-PAGE 
The reaction was stopped by the addition of EDTA (5 rnM final 
concentration ) . 
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2.3 PURIFICATION OF PROTEASE(S) FROM PUFFADDER VENOM. 
Lyophilized puffadder venom wa s obtained from Sigma and from the 
Transvaal Snake Park, Halfway-House, RSA. 
2.3.1 Cation exchange chromotography. 
The proteases of crude puffadder venom were not retaine d on DEAE-
cellulose (Van der Walt, 1970) so an attempt at purification was 
made using CM-cellulose equilibrated with 5 mM Na acetate pH 5.6 
eluted with a gradient of 5 mM Na acetate to o.35 M Na acetate pH 
5.6. The fractions were checke d for activity against f-D-dimer 
caseinolytic activity, and Chromozym activity. 
2.3.2. Purification of puffadder venom protease El_ gel-
filtration on Ultrogel AcA 34. 
Crude puffadder venom, 250 mg, was dissolved in l ml saline, 
filtered and applied to a column of Ultrogel AcA 34 (LKB), 
(20 0 x 2 cm), equilibrated with 0.1 M Tris/HC l buffer pH 7.4 
containing l mM cacl
2 
and 15 0 mM NaCl. The proteins were eluted 
wit h the same buffer at a flow rate of 50 ml/h (fractions 4 ml). 
Aliquots of the fractions were run on 4-20 % SDS-PAGE and stained 
wit h Coomassi e Blue. Aliquots, 50 pl, of the same fractions were 
incubated with 50pl of f-D-dimer at 37° C for 2 hours. The 
reaction was terminated by the addition of l00pl of SDS-sample 
buff er, 2 0pl aliquots run on 4-2 0% SDS-PAGE an~ the gel 
photographed under U.V.light. Fractions 135-165 showing maximum 
D-dimer cleavage activity were pooled, dialysed against 5 mM 
Tris/HCl pH 8.0 and loaded onto a column (20 x 2 cm) of DE 52 
cel lulose equilibrated with the same buffer. The proteins were 
eluted with a gradient of O - 0.15 M NaCl in the same buffer, 
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flow rate 60 ml / hour, fraction volume 6. 0 ml . 50 pl Aliquots of 
the fractions were run on 4-20 % SDS-PAGE and stained with 
Coomassie Blue, Aliquots o f the same fractions were incubated 
wit h f-D-dimer for 4 hours at 37°c. The reaction was stopped with 
an equal volume of SDS-sample buffer and aliquots run on a 6-10% 
SDS-PAGE and photographed under u.v. light prior to staining with 
Coomassie blue. Fractions 16-45 were pooled , concentrated by 
ultrafiltration and stored at 20°c. 
2 . 3 . 3 . Purification of puffadder venom orotease(s) E,Y gel 
filtration Qn Sephadex G 100 . 
Crude lyophilized venom, 100 mg was dissolved in saline to form 
a bright yellow milky suspension. The filtered venom contained 37 
mg of protein and was subjected to gel-filtration on Sephadex G 
100 (Pharmacia) equilibrated with 0 . 1 M Tris/HCl buffer pH 7.4 
containing 150 mM NaCl and 1 mM cacl 2
. Enzyme activity of the 
fractions was monitored by the cleavage of f-D-dirner (seen on 
SDS-PAGE under UV light), proteolysis of casein and hydrolysis of 
Chromozym TH. The fractions with activity against f-D-dimer were 
pooled and concentrated by ultrafiltration using Millipore CX 10 
immersible filtration units and subjected to a further gel-
filtration step on an Ultrogel AcA 54 column (100 x 2 cm) 
equilibrated with the same buffer as the previous gel-filtration. 
The fractions were again tested for D-dirner activity, pooled, 
concentrated and stored at -20°c, after adding glycerol to 50% to 
prevent freezing. The enzymes were stable for many months. 
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2.3.4. Purification of PAV protease EY means £.f HPLC. 
Protein, 1 mg from the peak on Ultrogel AcA 54 gel 
filtration that showed maximum activity against D-dimer was 
subjected to high performance liquid chromatography. The column 





pH 7.4. Flow rate was 1 ml / min and eluant monitored 
at 280 nm. 20 pl Aliquot of the fractions were tested for 
activity against f-D-dimer. Aliquots were run on SDS-PAGE. 
2.4 SEQUENCING OF THE CARBOXY-TERMINAL CYANOGEN-BROMIDE 
FRAGMENT OF THE t-CHAIN OF D-PAV-MONOMER. 
2.4.1 Preparation of D-PAV-monomer. 
Purified puffadder venom, 5 mg was added to a mixture of 
500 mg non-fluorescent and 5 mg fluorescent D-dimer in a buffer 
. 
0.lM Tris, pH 7.4, 150 rnM NaCl, 1 mM cacl
2
. The fluorescent D-
dimer was added to facilitate location of the 1-chain. The 
digestion was carried out for 18 hours at 37°c and monitored by 
SDS-PAGE in 4-20 % gels. The reaction was stopped by addition of 
5 mM EDTA (final concentration). 
The digest containing D-PAV-monomer was dialyzed against a 10 rnM 
Tris, pH 8.6 buffer and applied to a DEAE cellulose (Whatman) 
column (20 x 2 cm) equilibrated with the same buffer and the 
protein eluted with a gradient of 0-0.3 M NaCl. Fluorescent 
fractions were located by SDS-PAGE. A pool was made of the major 
fluorescent peak. 
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2.4.2 Isolation of i;:_. and §-chains from D-PAV-monomer. 
The D-PAV-monomer, 34 5 mg was made 6 M with respect to 
guanidinium hydrochloride and reduced and alkylated (Doolittle, 
1977b). The solution wa s desalted on a Sephadex G25 column 
equilibrated wit h a 1 0 mM Tris, pH 7.5 buffer containing 8 M 
urea. The reduced and alkylated t- and p-chains were separated on 
a DEAE-Sepharose CL 6B column (20 x 2 cm) equilibrated with a 10 
mM Tris , pH 7.5 buffer containing 8 M urea, and eluted using a 
gradient of 0-0.3 M NaCl. Aliquots were analysed by acid/urea 
PAG E.The pools from the major peaks were exhaustively dialysed 
against distilled water and lyophilized. The yield of ~-chain was 
100 mg. 
2.4.3 Cyanogen bromide digestion of the ~chain of 
D-PAV-monomer. 
Lyophilized i-chain, 30 mg was dissolved in 70% formic acid 
(5 mg / ml). Cyanogen bromide was added (10 mg/ml) and the reaction 
via l was kept under nitrogen for 18 hr at room temperature. The 
solution was thereafter diluted 10 x with distilled water and 
lyophilized. The dried peptides were dissolved in 10% acetic acid 
and molecular sieved on a Sephadex G 50 column (200 x 1 cm) using 
10 % acetic acid. The fluorescence in the fractions was detected 
after evaporation of the acid solvent by vacuum centrifugation 
and addition of 200 µl of 0.1% NH 4
Hco
3
• The fluorescent peak was 
pooled and lyophilized. 
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2.4.4 Isolation of the carboxy-terminal peptide from the cfchain 
of D-PAV-monomer. 
The lyophilized peptides were redissolved in 0.1 % NH 4Hco 3 or 
0.1 % TFA and separated by high performance liquid chromatograph y 
(HPLC). In order to visualize the fluorescent peptide (adde d at 
1:100 ratio) one HPLC separation used an alkaline ammonium 
bicarbonate buffer system with an acetonitrile gradient to elute 
from a RadialPak C8 column. It was anticipated that the 
fluorescent dansyl group could cause the peptide to be more 
hydrophobic and elute later. The relevant peaks were pooled and a 
portion of the pool run on an acid HPLC system. 
2.4.5 Peptide hydrolysis and amino acid composition. 
The Picotag (Waters) method was used to hydrolyse aliquots of the 
dried peptide (18 hours at 10s0 c under nitrogen with gas-phase 
6 N HCl hydrolysis). The Waters system for PITC amino acid 
derivatisation and separation was used. The carboxy-terminal 
peptide could be readily identified by the characteristic 
signature of the absence of serine and an appropriate amino acid 
composition. The yield of carboxy-terminal peptide was 
calculated on the basis of the lysine content. 
2.4.6 Manual gas-phase microsequencing EY Edman degradation. 
Reagents were all Pierce Sequanal grade. The method used was that 
of W.F .Brandt and G.Frank, Biochemistry Dept., UCT (not yet 
published). Oxygen scavengers and dithiothreitol were not added to 
reagents but these were always freshly opened or stored at -40°c 
under nitrogen. 
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Preparation of glass paper filter. 
A disc of Whatmans GF/C paper, 0.8 cm diameter, was inserted into 
a 2 cm glass tube with a drawn-out end. The filter was washed 
with trifluoroacetic acid (TFA) 100 pl, followed by 4 additions 
of 100 pl butyl chloride. This was repeated twice. and the glass 
filter dried in vacuo at 50°c for 15 minutes. Polybrene 
(Pierce), 10 pl of a 50 mg / ml solution in water was added to the 
center of the filter and then dried in vacuo for 15 minutes. The 
tube containing the filter was perched on glass tubing and placed 
together with a tube containing 0.5 mls TFA in a 50 ml Reaction 
bottle with a tap permitting evacuation and nitrogen replacement. 
The Picotag (Waters) vessels were convenient for this purpose. A 
blank cycle was performed by exposing the filter to TFA vapours 
at 50°c for 15 minutes. Thereafter the filter was washed with 3 x 
20 0 pl additions of ethyl acetate and then 2 x 200 µl additions of 
butyl chloride. 
Addition of sample. 
The filter was dried in vacuo and the peptide, 5 nmole in 10pl 
50 % TFA in water, was added accurately to the center of the 
filter and then dried in vacuo. 
coupling reaction. 
10 pl of 5% PITC in heptane was added to the centre of the 
filter. A tube containing 0.5 ml of 5% trieth_ylamine was also 
added to the reaction vessel that was then flushed with nitrogen 
and kept at 50°c for 40 minutes. The filter was dried in vacuo 
and washed with additiions of 2 x 200 pl heptane followed by 2 x 
200 pl ethylacetate and then dried in vacuo again (adequate 
drying was assessed by a pressure less that 50 millitorr). 
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Cleavage reaction. 
A tube containing 0.5 ml TFA was added to the reaction vessel and 
flushed briefly with nitrogen. After exposure to TFA vapour at 
50°c for 15 minutes the filter was dried briefly (to 200 
millitorr) and extracted with 3 x 200 fl washes of butyl chloride 
collected into a 10 x 75 mm tube (previousl y washed with TFA). 
The filter was dried in vacuo and was then ready fo r th e next 
cycle of the coupling reaction. The washings were dried in vacuo 
0 under a stream of nitrogen at 50 c. 
Conversion reaction. 
The dried thiazolinone was converted to the phenylthiohydantoin 
(PTH ) derivative by the addition of 1 drop of 50% TFA in water, 
heated at 90°c for 10 minutes in the reaction vessel. The tube 
was then dried in vacuo and the contents analysed by HPLC. 
Automated gas-phase microsequencing. 
A method was used in which a spinning cup sequencer was converted 
into a vapour (gas)-phase sequencer (Brandt et al, 1984). 
2.4.7 High performance liquid chromatography. 
A Waters system was used throughout with wavelengths of 214 nm or 
254 nm used for peptide detection together with fluorescence 
detection at alkaline pH. PTH-amino acids were detected at 254 
nm. Injections were manual and temperature was maintained at 
0 -
45 C. Flow rates were always 1 ml/minute. Peptides were separated 
by either: 
a) 5 µ Bondapak Cl8 (Waters) cartridge (8 mm x 10 cm) in a 
radial compression system. The column was equilibrated with 
0.1% NH 4Hco 3 and the sample eluted with a linear gradient up 
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to 25 % acetonitrile over 4 0 minutes and then up to 40 % over 
l t minutes. 
b} Ultrapore RPSC (Beckman} C3 column (4.6 x 75 mm} was 
equilibrated with 0.1% TFA in water containing 10 % 
acetonitrile and the sample eluted wit h a .linear gradient 
over 40 minutes up to 40 % acetonitrile in 0.1% TFA. 
Amino acid composition was performed using the complete Picotag 
(Waters} system with gas phase 6N HCl hydrolysis of samples and 
PITC derivatives and separation of the thiazolinone derivatives 
on the Picotag selected Cl8 column using commercial reagents . 
PTH amino acids were separated by either: 
a} Novapak Cl8 (Waters} column (3.9 mm x 15 cm}. The column was 
equilibrated with 5% tetrahydrofuran (Merck} containing 30 ml 
3M sodium acetate, pH 3.8 and 7 ml 3M sodium acetate, pH 4 . 6 
per litre. The sample was eluted with linear gradients of 
acetonitrile; 5 % over 2 minutes; 30% in 20 minutes; isocratic 
at 30 % for 2 minutes; 70% over 5 minutes. 
b} The same column was used with equilibration with Picotag 
Buffe~ A followed by elution of sample with a linear gradient 
over 20 minutes up to 30% acetonitrile in H
2
0 . Picotag Buffer 
A consists of 0.14 M sodium acetate containing 0 . 5 ml 
triethylamine per litre titrated to pH 6 . 40 with glacial 
acetic acid and 6% acetonitrile is added before use. 
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3. RESULTS 
3. 1 PURIFICATION OF FLUORESCENT AND NON-FLUORESCENT FIBRIN(OGEN) 
PLASMIN DERIVATIVES. 
3.1.1 The purification of fluorescent and non-fluorescent D-dimer. 
Fluorescent D-dimer was isolated from an over-night plasmin 
digest of dansyl cadaverine substituted fibrin. Aliquots of 
fractions collected after DEAE-cellulose anion exchange were 
analyzed on a 4-20 % SDS-PAGE (Figure 8A). The gel was 
photographed under u.v. light and the fluorescent fragments 
located prior to staining with Coomassie Blue (Figure 8B). 
The fractions containing f-D-monomer and f-D-dimer, and those 
containing f-D-dimer and fragment E were pooled and concentrated. 
Due to non-covalent binding of fragment E to fragments D-monomer 
and D-dimer (Olexa and Budzynski, 1979) the buffers for molecular 
sieving contained 4M urea. D-dimer was separated from other 
fragments by molecular sieving on a column of Ultrogel AcA 34 
(Figure 9A). Aliquots of fractions collected were run on a 
4-20% SDS-PAGE and f-D-dimer located by fluorescence under u.v . 
light prior to staining with Coomassie Blue (Figure 9B). 
3.1.2 Purification of fluorescent D-monomer 
Fluorescent fragment D was a contaminant of fluorescent D-dimer 
preparation due to partial inhibition of cross-linking by dansyl-
cadaverine. It appeared to be identical to plasmin D-monomer 
with respect to molecular weight and physical properties (Purves 
et al, 1980). Non-fluorescent D-monomer was prepared from an 
overnight plasmin digest of fibrinogen, the necessary calcium 
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Figure 8. Anion exchange chromatography of a plasmic digest of 
dansyl-cadaverine labelled fibrin. 
A. The dialysed, filtered digest was loaded onto a cellulose 
DE 52 column (20 x 2 cm) and eluted with a gradient of 
NaCl, 0 - 0.3M. Flow rate 80ml/h. 
B. Aliquots of the fractions were run on a 4-20% SDS-PAGE, 
and the wet gel photographed under u.v. light 
prior to staining with Coomassie Blue. 
Fractions containing f-D-monomer and f-D-dimer were pooled, 














Figure 9. Gel filtration of pooled concentrated fractions 
containing f-D-dimer. 
A. A column of Ultrogel AcA 34 (200 x 1cm) was 
equilibrated with 0.1 M Tris/HCl buffer , pH 7.5, 
containing 150 mM NaCl and 4 M urea. 
B. Aliquots of the fractions were run on a 4-20% SDS-PAGE 
and photographed under u.v. light prior to Coomassie Blue 
staining. 
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avoid clotting of the fibrinogen. The D-monomer was isolated 
using the same method as for the D-dimer. 
3.1.3 Purification of non-fluorescent D-dimer. 
Non-fluorescent D-dimer was isolated from a plasmic dig est of 
non-fluorescent fibrin in the same wa y as f- D-dimer (Figure 1 0 ). 
3.1.4 Purification of D-PAV-monomer. 
D-PAV-monomer was isolated as described in the methods from an 
overnight digest of fluorescent or non-fluorescent D-dimer using 
the enzyme isolated from puffadder venom and buffers containing l 
mM zncl
2
• The D-PAV-monomer was isolated by DEAE-cellulose 
anion-exchange chromatography and/or molecular sieving on 
Ultrogel AcA 34. Purit y and molecular weights of the 
isolated fragments used on experiments wit h PAV protease 
(Figure 12). 
3.2 PURIFICATION OF PUFFADDER VENOM PROTEASE. 
The enzyme used to study the D-domain of fibrin was puffadder 
venom protease I, first isolated and characterized by van der 
Walt (1971). 
3.2.l CM cellulose cation exchange chromatography. 
Crude venom (lg) was chromatographed on CM cellulose. The 
fractions were tested using Chromozym TH, and p-dimer as 
substrates. The D-dimer cleavage activity extended over a number 
of rather ill-defined peaks, and was clearly separated from the 
peak containing Chromozym TH activity (Figure 13). The enzyme 
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Figure 10. A. Anion exchange chromatography of a plasmic 
digest of fibrin. 
The proteins were loaded onto a cellulose DE 52 column 
(20 x 2 cm) equilibrated with 5 mM Tris/HCl buffer 
pH 8.6, and eluted with an NaCl gradient 0-0.3 M. 
B. Aliquots of the fractions were run on a 4-20% 
SDS-PAGE and stained with Coomassie Blue. The fractions 
containing D-dimer were pooled, comcentrated and 












Figure 11. Gel-filtration of D-dimer 
on Ultrogel AcA 34. 
After concentration the fractions cont
aining D-dimer were 
applied to a column of Ultrogel AcA 34
 (100 x l cm) 
equilibrated with 0.1 M Tris/HCl buffe
r, pH 7.4, containing 
150 mM NaCl.The proteins were eluted with
 the same 
buffer, flow rate 30 ml/hour. 
8 0 
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Figure 12. SDS-PAGE of materials used as substrates for 
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Figure 13. Fractionation of crude puffadder venom on CM 
cellulose. 
Crude puffadder venom, 100 mg in 5 mM Na acetate buffer 
was applied to a column of CM cellulose (20 x 2 cm) 
equilibrated with the same buffer. The proteins were 
eluted with a linear gradient of 5 mM - 0.35 M Na acetate 
pH 5.6. (---) = fractions with Chromozym activity. 
The bar indicates the fractions with D-dimer cleavage 
activity. 
3.2.2 Gel filtration of puffadder venom proteases. 
a) Gel filtration on AcA 34: 
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Crude puffadder venom, 230 mg was dissolved in saline, filtered 
and applied to an AcA 34 column (2 metres x 2 cm} equilibrated 
with 0.lM Tris/H Cl ph 7.4, 150 mM NaCl, l mM CaC1
2
, 1 mM ZnC1 2 
buffer. The venom separated into four peak s (Figure 14A). The 
fractions were assayed for caseinolytic and D-dimer cleavage 
activity. There were two main peaks of caseinolytic activity 
(Figure 14A) .Aliquots of the fractions were assayed for D-dimer 
activit y , the peak being from fraction 135 to 160 (Figur e 14C}. 
These fractions were pooled, dialysed and applied to a cellulose 
DE-52 column (20 x 2 cm) equilibrated with 5 mM Tris pH 8.0 and 
eluted with an NaCl gradient from 0 to 0.15M (Figure 15A}. 
The starting material contained proteins wit h molecular weights 
ranging from+ 30,100 to~ 15,000. The material fractionated 
into fractions containing a protein of+ 25,000 (fractions 5-9) 
and~ 29,000 (fractions 33-41, Figure l5B) D-dimer cleavage 
activity was found in fractions 9-48 with the most active peak 
being fractions 5 to 15 which were pooled (Figure 15C). 
b) Gel filtration on Sephadex G 100. 
Puffadder venom separated into three main peaks with molecular 
sieving on Sephadex G 100 (Figure 16A). D-dimer cleavage 
activity occured in peak 3 (Figures 16A & B), ~aximum Chromozym 
TH activity in peak 2, and caseinolytic activity in peaks 1 and 3 
(Figure 16A). There was no activity against TAME, BTEE or ATEE 
in any of the peaks.The three peaks were pooled and concentrated 
by ultrafiltration. The activity of each pool with Chromozym TH 
was determined. EDTA (final concentration 5 mM) had no effect on 
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Figure 14. Gel filtration of crude puffadder venom on Ultrogel 
AcA 34 . 
A . Crude puffadder venom, 250 mg dissolved in saline was 
applied to a column of Ultrogel AcA 34 (200 x l cm) 
equilibrated with 0.1 M Tris/ HCl buffer pH 7 . 4 
containing 150 mM NaCl and l mM CaC12. The proteins were 
eluted with the same buffer. Flow rate 30 ml / hour. 
Aliquots of the fractions were assayed for caseinolytic 
activity. 
OD 280 (~) 
caseinolytic activity ( - - - ) 
B. Aliquots of fractions were run on 4-20 % SDS-PAGE and 
stained with Coomassie Blue. 
c. Aliquots of the fractions were incubated with f-D-dimer 
for two hours at 37oC, run on SDS-PAGE and the wet gels 
photographed under u.v. light prior to staining wit h 
Coomassie Blue. 
Fractions indicated by the bar were pooled dialysed and 
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Figure 15. Fractionation of the dialysed pooled fractions 
from the AcA 34 gel filtration of crude puffadder venom. 
A. The pooled dialysed fractions were applied to a column 
of cellulose DE 52 (20 x 2 cm) equilibrated with 5 mM 
Tris/HCl buffer pH 8.0 and eluted with a linear gradient 
of NaCl in buffer from 0 - 0.15 M. 
B. Aliquots of the fractions were run on a 4-20% gradient 
SDS-PAGE and stained with Coomassie Blue. 
c. continues overleaf 
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Figure 15 contd. 
C. Aliquots of the fractions were assayed for f-D-dimer 
cleavage activity and run on a 4-20% gradient SOS-PAGE, 
photographed under U.V.light and stained with Coomassie 
Blue. Fractions 5-50 were all active against f-D-dimer 
with the strongest cleavage activity in fractions 5 - 15 
associated with a protein of 25,000 daltons as compared 
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Figure 16. Molecular sieving of crude puffadder venom on 
Sephadex G 100. 
A. The filtered venom containing 37 mg protein was applied 
to a column of Sepahadex G (100 x 2 cm) equilibrated 
with 0.1 M Tris/HCL buffer pH 7.4 containing 
150 rnM NaCl and l mM CaC12. 
The proteins were eluted with the same buffer. Flow rate 
30 ml/h, fraction volume 3.0 ml. 
= OD 280 nm; 
••••••• = caseinolytic activity; 
- - - - = activity with chromozyrn TH (t-gly-pro-arg-pNA) 
B. SDS-PAGE of PAV fractions incubated with D-dimer for 
4h at 37oC. 
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the Chromozym activity of pools 1, 2 and 3 (Figure 1 7 A). A timed 
digest of f-D-dimer wit h each of the t h ree poo ls was performed. 
Aliquots were withdrawn at 2', 5' ,1 0 ', 15', 25' and 35 minutes 
and analyzed on a 4-20 % SDS-PAGE. Most of the Chromozym activity 
was associated wit h pool l,a small amount wit h pool 2 and no 
activit y at all in pool 3. The enz ymes in pool l were unable to 
cleave D-dimer despite having a high caseinolytic activity. 
Pool 2 was weakl y active against D-dimer. Pool 3 was very active 
against D-dimer giving · rise to D-PAV-monomer after 10 minutes 
(Figure 17B ) . The concentrated pool 3 was applied to an Ultrogel 
AcA 54 column (100 x 2 cm) (Figure 18A). The main fraction 
contained a protein with maximal activity against D-dimer 
(Figure 18C). 
The size of this protein was approximately 25,000 daltons, and 
several smaller components were separated on SDS-PAGE. rhe smaller 
proteins are probably associated in solution , since they emerge 
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Fi gur e 17. Activity o f pools 1, 2 and 3 with chromozym TH, 
an d f-D-dimer as substrates. 
A. Activity of 
substrate. 










In all cases 100 mg of protein was used in the assay. 
The assay was performed as described in the methods. 
The arrows indicate the time at which EDTA was added 
(final concentration 5 mM) to the assay. 
B. Pools 1,2 and 3 from Sephadex Gl00 gel-filtration 
were concentrated and a timed digest with f-D-dimer 
as substrate performed. A 50 pl aliquot was withdrawn 
at each time interval and added to an equal volume of 
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Figure 18. Purification of pool 3 from Sephadex Gl00 column, 
on Ultrogel AcA 54. 
A. Molecular sieving of pool ~ on Ul trogel AcA 54 
column (10 0 x 2 cm) • 
B. Aliquots of fractions run on 6 - 10% SDS-PAGE and 
stained with Coomassie Blue. 
c. SDS-PAGE of fractions incubated with f-D-dimer at 
37oC for 2 hours. 
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3.2.3 High performance liquid chromatography of puffadder venom 
protease. 
An aliquot from the pooled and concentrated Peak 3 from the 
Sephadex G 100 gel filtration gave several peaks on HPLC 
(Figure 19A). Maximal D-dimer activity was .found in peak 6 
(fractions 15 and 16) (Figure 19B), associated with a protein of 
molecular weight~ 25 ,00 0 daltons (Figure 19C). 
3.3 Characterization of puffadder venom protease. 
3.3.1 Identity of the PAV protease. 
Although this enzyme is probably the same as protease I 
isolated and characterized by van der Walt (1971), its specific 
effects on fibrin and fibrinogen have not yet been studied. It 
inhibits clotting of fibrinogen (Figure 20). It is capable of 
lysing fibrin clots albeit at a much slower rate than plasmin. 
h comparison between digestion of fibrinogen by plasmin and 
purified puffadder venom protease shows that PAV enzyme rapidly 
degrades the ca_-chain, then the p-chain at a slower rate, and 
appears to leave the t-chain intact even after lengthy 
incubation. Plasmin degrades all three chains 
( F i g u r e 2 lA & B ) • 
3.3.2 Comparison of PAV protease and plasmin activity using 
chromogenic substrates. 
various chromogenic serine protease substrates_ were tested with 
crude PAV, and compared to plasmin activity with Chromozym PL. 
PAV showed the greatest activity with Chromozym TH (Figure 22). 
The activity was unaffected by the addition of Zn++ or EDTA. 
The pools of the three peaks from Sephadex G 100 were each tested 
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Figure 19. Purification of PAV by means of high performance 
liquid chromatography (HPLC). 
A. 1 mg of protein from pool 3 of Sephadex G 100 gel 
filtration was subjected to HPLC. Column Ultrapak 




Flow rate 1 ml / min. Fraction volume 1 ml. 
B. 20µ1 aliquots of the fractions were assayed for 
f -D-dimer cleavage activity and run on a 4-20% 
SDS-PAGE and photographed under u.v. light. 
C. Aliquots of the fractions were run on a 6-8% 
SDS-PAGE and stained with Coomassie-Blue. The 
fractions with maximum f-D-dimer cleavage activity 
were associated with a protein of molecular weight 
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Figure 20. The effect of PAV protease on the clotting time of 
fibrinogen. 
Fibrinogen was incubated for 30 minutes at 37°c 
with crude PAV protease. At 5 minute intervals aliquots 
were withdrawn, calcium and thrombin added and the time 
noted for a clot to develop. Purified PAV protease 
rendered fibrinogen incoaguable after 30 seconds. 
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Figure 21 . Comparison of digestion of fibrinogen by plasmin 
and PAV protease . 
A. Fibrinogen (10 mg / ml) was incubated with plasmin at 
37oC in buffer containing l mM CaCl . 
Aliquots were withdrawn at timed iniervals and run 
on 4-20 % SDS - PAGE under non-reducing (SDS) and 
reducing (BME) conditions. 
B . Fibrinogen incubated with PAV protease using same 
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Figure 22. Activity of crude puffadder venom with Chrornozyrn 
substrates. 
1 = Chromozym PL + plasmin (10µg) 
2 = Chromozym PL + PAV (100 ,ug) 
3 = Chromozyrn TRY + n 
4 = Chromozym PK + n 
5 = Chromozym TH + n 
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3.3.3 Caseinolytic activity of PAV protease. 
The pH optimum for caseinolytic activity of PAV protease was 
established using buffers with pH ranging from 7.0 to 10. The pH 
optimum for caseinolytic activity of PAV protease is about pH 9.0 
(Figure 23). 
3 . 4 DEFINITION OF PAV PROTEASE ACTIVITY USING D-DIMER FROM 
CROSS-LINKED FIBRIN AS SUBSTRATE. 
Before using puffadder venom as a tool in the study of the 
D-domain of fibrin it was necessary to define parameters for its 
activity with respect to D-dimer. The fluorescence spectra of 
f-D-monomer, f-D-dimer and the fluorophore dansyl cadaverine were 
determined (Figure 24). 
3.4.1 Timed digest of fluorescent D-dimer E.Y PAV protease. 
The assays for D-dimer activity were carried out at pH 8.0. 
Fluorescent D-dimer was incubated with PAV protease and aliquots 
for given times were run on a 4-20°c SDS-PAGE (Figure 25A & B). 
The D-dimer is cleaved to a monomer with the same molecular 
weight as D-monomer-plasmin. After two and three hours of 
digestion a second D-monomer (D-PAV-monomer) can be seen with a 
slightly smaller molecular weight (Figure 25A, lane 4J. The 
activity of the PAV protease was also followed with a 
spectrofluorimeter. Both fluorescent D-dimer and fluorescent 
D-monomer showed a decrease in absolute fluorescence during PAV 
digestion (Figure 26A). Only fluorescent D-rnonomer species, with 
no fluorescent fragments, were produced on PAV digestion and the 

















Figure 23. Optimum pH of PAV protease with casein as 
substrate. 
10 
Caseinolytic activity of PAV protease was determined 
in Tris/HCl buffer of different pHs. 
The optimum activity was found to be at pH 9. 
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Figure 25. Timed digestion of fluorescent D-dimer 
by PAV protease showing the distinct single (-chain. 
f-D-dimer (1 mg/ml) was incubated with PAV protease 
(10 pg/ml) at 37oC. Aliquots were taken at 0, 1, 2, 3 
and 4 hour intervals and analysed by SDS-PAGE under 
reducing (}'1ME) and non-reducing conditions. The gel was 


































PAV dilutions (2-x) 
Figure 26. Changes in fluorescence during digestion of 
f-D-dimer with PAV protease. Excitation wavelength 
340 nm, emission wavelength 520 nm. 
A. Decrease in the initial fluorescence of f-D-dimer 
and f-D-monomer with time. Both species are converted 
to a form of f-D-monomer smaller than plasmin 
D-monomer. 
B. Relative changes in amounts of f-D-dimer and 
f-D-monomer after lh (~-)and 2h (- - -) digestion 
with dilutions of PAV. The undiluted venom contains 
0% f-D-dimer and has been completely converted 
to f-D-monomer for both durations. 
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by fluorescent scanning of PAGE gels of f-D-dimer that had been 
exposed for one or two hours to dilutions of PAV (Figure 26B). 
3.4.2 Effect of zinc ions on PAV protease activity . 
The change in fluorescence during conversion of f-D-dimer 
to f-D -monomer PAV protease was used to study the effects of added 
zinc on the enzyme. The effect of added zinc was to increase the 
loss of absolute fluorescence immediately but the same final 
value was attained whether the zinc was added at zero time or 
later (Figure 27). There was a 10 fold potentiation of enzyme 
activity when zinc was added. The correlation of changes in 
absolute fluorescence and D-dimer cleavage was confirmed by SDS-
PAGE of aliquots taken during the digestion. These changes in 
fluorescence probably reflect changes in the hydrophobic 
environment of the dansyl group on the substituted cross-link 
site. This is possible since the cross-link sites must both lie 
between the large D-domains. 
3.4.3 Effect of inhibitors on PAV protease activity. 
A preliminary study of inhibitors revealed that only metal 
che lators e.g. EDTA, were effective (Figure 28). No other class 
of effective inhibitor e.g. mercury compounds, fluoride 
compounds, chloromethylketones, or bacterial inhibitors e.g. 
clostripain, pepstatin or leupeptin have been found (Figure 29). 
Calcium appears to play no role in the action of PAV or in 
determining the susceptibility to PAV digestion even when 
plasmin-susceptible D-dimer (Chelex-treated D-dimer, very low 
C ++ . a concentration) was used. The presence or absence of the E-
domain associated with the D-dimer did not alter susceptibility 












40 0 1000 seconds 
Figure 27. The decrease in absolute fluorescence of 
f-D-dimer on digestion with PAV is potentiated 
by the addition of Zn++ but the same total 
decrease is attained. 
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Figure 28. Caption overlea f 
A 






Figure 28. The effect of various in h i b itors, calcium, and 
zinc ions on th e cleavage o f f-D-dimer by PAV. 
A. Fluorescence picture o f SOS-PAGE . 
B. SDS-PAGE stained with Coomassi e Blue. 
Lanes 1 LMW standards 
2 f-D-dimer 
3 II + PAV + hexane-diamine 
4 II + PAV + PMS F 
5 II + PAV 
6 II + PAV + 1 mM EDTA 
7 II + PAV + 3 mM EDTA 
8 II + PAV + 1 mM EDTA + 1 mM ZnC1
2 
9 II + PAV + 3 mM EDTA + 1 mM ZnC1 2 10 f-D-dimer Chele x treated 
11 II + PAV + 0 .1 mM CaC1
2 12 II + PAV + 1. 0 mM Cacl 2 13 II + PAV + 0 .1 mM ZnC1 2 14 II + PAV + 1. 0 mM ZnCl 
15 n plasmin t ++ + + 1.0 mM a++ 
16 II + plasmin + 0 .1 mM Ca 
17 HMW standards 
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Figure 29. Effect of inhibitors on the decrease in fluorescence 
of f -D-dimer on digestion with PAV. 
1 = f-D-dimer 
2 II PAV + Zn ++ = + 
3 = II + PAV + Zn ++ + 5 mM EDTA 
4 = II + PAV + DMSO 
5 = n II + chymostatin 
6 = n II + leupeptin 
7 = n II + pepstatin 
8 = n II + PMSF 
Final concentration of inhibitors 1 mM. 
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3 .4. 4 Comparison of PAV proteas e with plasmin using D- dimer as 
substrate . 
Pla smi n is unable to cleave D-dimer in the presence of 
physiologica l concentration s of c a lcium (Figure 28, lane 15 &16) . 
If c alcium is chelated plasmin degrades D-dime r to several 
spec ies of D- monomer from D1 
to D
5 
(Purves et al,197 8) . The 
smal ler D species are due to progressive shortening of the 
f-c hain from the carboxy-terminal end. The final product is two 
smaller D-mo nome rs and a cros s -linked peptide which remains 
associ ated with th e D-monomer s (Figure 30). 
The earliest event in the action of PAV protease appears to 
be t he cleavage of the di-~-bond with the production of only one 
size of i-species, either fluorescent or non-fluorescent (Figure 25) 
and separation of t he dimer into monomers (Figure 31A) . The fl-chain 
is hydrolysed at a slower rat e and this is a progressive p roces s 
yielding a smaller chain size (~-PAV ) . Early in the digestion 
two species of f - D-monomer were seen (Figure 31A, lane 4) , 
sugg esting that cleavage of th e di-t-bond can precede and be 
independent of the prog ressive reduction in size of the !3-chain 
that determines the smaller D-monomer species. 
3.4.5 Cleavage of D-dimer EY venom from different species of 
snakes. 
venom from seven members of the Viperidae and one Elapid 
snake were tested for D-dimer cleavage activity. Three out of 
the seven showed some activity, suggesting that the venom from 
Trimeresurus gramineus, T.okinavensis and Bothrops atrox may 
contain an enzyme similar to protease I from Bitis arietans. The 
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Figure 30. Timed digest of f-D-dimer with purified PAV 
protease compared to digestion of f-D-dimer by plasmin 
in the absence of calcium ions. 
A. f-D-dimer (lmg/ml) was incubated with purJ!ied PAV 
(10 ~g/11) at 37oC in buffer containing ca 
and ZnT • At the times shown aliquots were withdrawn 
and added to SDS sample buffer and run on a 4-20% 
SDS-PAGE. The gel was photographed wet under U.V. 
light prior to staining with Coomassie Blue. 
B.f-D-dimer was digested with plasmin under the same 
conditions as A except that the Ca was chelated 
with EDTA . This resulted in the excision of a cross-
linked fluorescent peptide from f-D-dimer giving rise 
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Figure 31. Timed digestion of f-D-dimer by PA
V. 
f-D-dimer was incubated with PAV protease for
 20 
minutes at 37oC .Aliquots were withdrawn at th
e times 
shown and run on a 4-20% SDS-PAGE. The wet g
el was -
(A) photographed _under u.v. light 
(B) prior to staining with Coomassie blue. 
After 10 minutes of digestion two D-monomer 
bands can be 
seen, both these bands are fluorescent. On re
duction 
three bands can be seen that were identified 
as -
1) f-t-cha in, 
2) plasmin-,,8-chain and 
3) PAV-.,8-chain in decreasing order of size. 
Only a single species off-~ is produced with
 no 
fluorescent fragments but a plasmin-D-monome
r is the 
first product with a smaller D-PAV-monomer la
ter 
(note double band in lane 4 in SDS run). 
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Dendroaspis polylepis (black mamba), Crotalus adamanteus (diamond 
-bac k rattlesnake), Echis carinatus (saw-toothed viper) and 
Causus rhombeatus (night adder) showed no D-dimer cleavage 
activity (Figure 32). 
3.4.6. Effect of PAV protease~ o-dimer derived from rat fibrin. 
Fibrinogen was prepared from rat plasma as described in the 
methods. It was clotted in the presence of thrombin and calcium 
and the clot digested with plasmin .The resulting D-dimer was not 
purified further, but PAV protease added directly to the plasmin 
digest. Aliquots were removed at various time intervals up to 2 
hours and analyzed on a 4-20% SDS-PAGE with non-re<lucing (SOS) 
and reducing (BME) conditions and stained with Coomassie Blue . 
After 30 minutes there is an increase in D-monomer (Figure 33A) 
and the two B-chains can be seen (Figure 33B). 
3.5 IMMUNOLOGICAL APPROACH 'ID THE STUDY OF THE D-DOMAIN OF 
FIBRIN. 
The advent of monoclonal antibody techniques has opened up 
new possibilities for the identification of fibrin / fibrinogen 
degradation products. The main avenue of attack has been the 
exposure of normally sequestered epitopes in an effort to 
distinguish the different antigens present in plasma in normal 
and disease states. 
In this work a start has been made in the development of a 
monoclonal antibody to the site exposed by action of puffadder 
venom on D-dimer. The reactivity of D-PAV-monomer was tested 
against existing monoclonal antibodies developed by Rylatt. 
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Figure 32. A two hour digest o f f - D-dirner wit h nin e 













1 = LMW Stds. 
2 = Cerastus cerastus 
3 = Trirneresurus grarnineus 
4 = Crotalus adarnanteus 
5 = Dendroaspis polylepis 
6 = Echis carinatus 
7 = Causus rhornbeatus 
8 = Bothrops atrox 
9 = Trirneresurus okinavensis 
10 = Bitis arietans ( puffadder 
11 = f-D-dirner 
12 = HMW Stds. 
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D-dimer ___ .. __ _ 
-- ~J) 
__ .... __ 
-------.., D-monomer ....... _ 
Figure 33 . Timed digest of rat D-dimer by PAV protease. 
Rat D-dimer was incubated with PAV protease for 2 hours 
at 37oC. Aliquots were withdrawn at the times shown and 
analyzed by SDS-PAGE with 
A. non-reducing conditions 
l - human D-d irner 
2 II + PAV 2 hours 
3 - rat D- dimer 
4 - rat D-dimer + PAV 2 rnins 
5 - II 5 
6 - II 10 
7 - II 20 
8 - II 30 
9 - II 60 
10 - II 120 
B. reducing conditions. 
11 - II 0 mins + J3ME added 
12 - II 5 II 
13 - II 30 II 
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3.5.1 Radioisotope assay for D-dimer. 
A standard curve was performed (Figure 34). 
All assays were performed in duplicate. D-PAV-monomer showed 
ver y little reaction with the monoclonal antibod y directed at 
D-dimer (Figure 35) . 
A second assay was performed in which the wells were coated 
wit h D-dimer and PAV protease added to wells and left overnight, 
thus converting the bound D-dimer to D-PAV-monomer, whic h again 
showed very little reaction to the second antibody. 
D-PAV-monomer showed ver y little reaction with the monoclonal 
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1 = D-dimer standard 
2 = f-D-dimer 
3 = plasmin D-monomer 
4 = D-PAV 
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= D-dimer standard 
incubated for 1 hour 
= D-dimer standard 
incubated overnight 
= D-dimer + PAV incubated 
for 1 hour 
= D-dimer + PAV incubated 
overnight 
Figure 36. Radioisotope immunoassay with PAV added to the wells. 
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3.5.2 Dimertest agg l utination assay . 
f-D-dimer digestion wa s carried ou t at 37°c wit h p l asmin and 
EDTA, and PAV p rot e ase. Aliquot s we r e wit hd rawn at t ime 
interval s f rom 0 t o 4 hour s and run on SDS - PAGE (Figure 3 0 ). 
Another 2 0 jll aliquot wa s diluted 1 / 1 0 (~ 500 ng) and tested wit h 
the Dimertest agglutination assay (Ta b l e I II ). 
Table III: Reactivity of PAV protease and plasmin digested D-dimer 
with the Dimertest monoclonal antibody to D-dimer. 
Time 0 I 5 I 10' 
PAV + + + 








3.6 Sequencing of the carboxy-terminal cyanogen-bromide fragment 
of the i-chain of D-PAV-monomer. 
The D-PAV-monomer from the DEAE-cellulose column was 
col l ected by pooling the fluorescent samples (due to the initial 
add i tion of 1 % fluorescent D-dimer). After reduction and 
alk ylation the p and i-chains were clearly separated by anion 
exc hange chromatography as shown by acetic acid/ urea PAGE 
(Figure 37). After cyanogen bromide cleavage of the purified 
~-chain the peptides were separated by molecular sieving. The 
lyophilised fractions, made alkaline with ammonium bicarbonate, 
showed that the fluorescence was located at one end of the fa peak 
(Figure 38). This distribution conformed with the expectation of a 
carboxy-terminal peptide, 2864 daltons, with the other peptides 










































Figure 37. Isolation of reduced and 
(345 mg), on a DEAE-Sepharose CL 





alkylated J.- and y-chains 
6B column (2 x 20 cm) 
buffer pH 7.5 containing 
Flow rate 34 ml/hour. Fraction volume 2.25 ml. 
Absorbance 280 nm (~-). Fluorescence in arbitrary units 
(- - -) , excitation 340 nm, emission 520 nm (from the 
addition of 1% dansyl cadaverine substituted D-dimer to 
the starting material in the preparation of D-PAV-monomer). 
t-chains were pooled as indicated: 
Inset. PAGE of indicated fractions in an acetic 
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Figure 38. Separation of the cyanogen-bromide peptides of 
the i-chain of D-PAV-monomer (3 0 mg) on a Sephadex G 50 
column ( l x 2 0 0 cm) in l 0 % ace t i c a c id • 
Flow rate 10 ml/hour. Fraction volume 1.0 ml. 
The hatched area indicates the fluorescent fractions 
that were pooled ( see methods). 
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The dansyl-cadaverine substituted peptide was clearly separated 
from the main unsubstituted peptide(s) (Figure 39) in HPLC under 
alkaline conditions using a RadialPak (Waters) CB column. The 
precise molecular constitution of the fluorescent peptide has not 
been studied further yet except to note that two main species 
appeared to be present as is the case with the unsubstituted 
peptides. The amino acid composition of the HPLC fractions 
showed that peaks A and B (Figure 39) both had the hallmarks of 
the carboxy-terminal peptide viz. no serine; equimolar valine, 
phenylananine, proline and threonine and more isoleucine than 
leucine (Table IV). There were minor differences in amino acid 
~omposition between peaks A and B. HPLC of individual peaks in an 
acid system again yielded two peaks. Peaks A & B were therefore 
pooled and run on an acid HPLC system and this yielded two 
overlapping peaks (Figure 40, peaks D, E) with similar amino acid 
composition and sequences. 
The amino acid composition (Table IVA) showed that certain amino 
acids were at lower levels than expected - notably leucine, 
glycine, histidine, glutamine and possibly isoleucine. These 
amino acids, with the exception of isoleucine, occur as a group 
and could have been removed by exopeptidase activity after a 
chain cleavage (Table IVB). The deficient isoleucine could be 
due to incomplete hydrolysis of the two adjacent isoleucine 
residues in positions 2 and 3 of the peptide. subsequently, the 
expected three isoleucine residues appeared in the sequence 
(Ta ble V). since the sequence of the 27 residue carboxy-
terrninal peptide of the ~-chain is known (Figure 7), identities 
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Figure 39. HPLC separation of the carboxy-terminal pe
ptides 
of the i-chain of D-PAV-monomer from the pooled fractio
ns 
(Figure 31) using a RadialPak CB (Waters) column. 




acetonitrile and the sample was eluted with an 
acetonitrile gradient up to 40%. Flow rate lml/minute. 
Absorption 254nm (~-) and fluorescence in arbitrary 
units (- - -) (Waters detector). Peaks A and B were 
both shown to be carboxy-terminal peptides on the basis
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Figure 40. HPLC separation of pooled carboxy-terminal peptides (peaks A and B, Figure 32), on an Ultrapore 
RPSC (Beckman) C3 column. 
The mobile phase was 0.1% TFA containing 10 % acetonitrile and the peptides were eluted with a linear acetonitrile gradient over 30 minutes from 10% to 40%. Peaks D and E were both shown to be carboxy-terminal peptides on the basis of amino acid composition. ( Two peaks were also seen when either peak A or B were applied separately - see discussion for comments on 
heterogeneity) • 
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checked on a different PTH analysis system. Arginine (residue 7) 
was not identifiable as a single peak and threonine was present 
. only as very hydrophobic dehydrothreonine with carry-over for 2 
cycles. At residue 14, glutamine was found as well as a new peak 
(Table V, DP) eluting very early. A smaller amount of 
glutamine, possibly carried over, was found at residue 15 
together with the early peak in larger amounts. The exact 
constitution of this early peak could not be ascertained but the 
synthetic dipeptide t-L-glutamyl-€-L-lysine, when subjected to 
the gas phase procedure, eluted in a similar position albeit with 
a few unidentified minor peaks. The di-PTH derivative of the 
dipeptide made by a solution method, however, yielded material 
eluting near to lysine but distinct from it and on hydrolysis in 
6N HCl (gas phase) and re-derivatisation with PITC and conversion 
to the PTH derivative yielded glutamic acid and lysine. The 
differences have not been investigated further. Histidine was 
present in substoichiometric amounts (Table IV) suggesting a 
degree of heterogeneity . The manual sequence showed histidine to 
be present at residue 16 and possibly also at position 17. 
However , carry-over could not be excluded as the histidine was 
the terminal residue at either position 16 or 17 . The carboxy-
terminal amino acid of the i-chain , i . e . valine, was seen in good 
yield despite its terminal position but occurred at cycle 7. 
The first cycle and the third to seventh cycles showed the 
presence of two residues . The second cycle contained only a 
single residue . The eight to thirteenth cycle showed a clearcut 
single residue and were all easily identified. Glutamine and a 
putative dipeptide (DP) were present at cycles 14 and 15 but with 
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Table IV 
A. Amino acid composition of isolated peptide (Peak A, Figure 
Amino Corrected *a Probable Expected Difference 
acids and normalised number number 
N + D b 2 . 07 C 2 . 96 2 2 
Q + E 2 . 25 3 . 21 2 , 3 4 - 1 ,- 2 
s 0 0 0 0 
G 1. 9 0 2 . 71 2,3 5 - 2 ,- 3 
H 0 . 34 0 .4 8 0 , 1 2 - 1 ,- 2 
R 1. 05 1 . 40 1 1 
T 0 . 86 1 . 22 1 1 
A 1. 76 2 . 5 2 2 
p 1 1 .4 0 1 1 
V 0 .7 0 1 1 1 
I 1. 60 2 .2 8 2 , 3 3 - 1 
L 0 . 73 1. 04 1 2 - 1 
F 1. 05 1.50 1 1 
K 1. 70 2 .4 2 2 2 
B. Carboxy-terminal cyanogen bromide peptide of the human 
fibrinogen i-chain. 
39) 
d * * * Sequence KI IP F N R LT I G E G Q Q H H LG GA K QA GD V 
e Losses ( i) (q h) H L G G 
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Table IV Caption. 
a Corrected for recovery of hydrolysed amino acid standards. 
b , C b C 
No rmalised to 1 residue - P , v. 
The values of probable and expected are given as residues per mole. 
The known sequenced is aligned against the missing residues 
e 
* 
(g h) represents probable extra losses in a subfraction 
of the peptide . 
(i) the ratio of I to L was always 2 : 1 - 3 :l expected. 
Partial hydrolysis of II could be responsible for low yield . 
Crosslink sites - at Q an d K. 
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Table V Gas-phase Edman degradation microsequencing. 
MANUAL AUTOMATED 
Residue Carry Residue carry Residue Residue 
Cycle 1 over 2 over 1 2 
1 K 8 . 0 0 A 4. 0 0 K 9. 6 A 12.0 
2 I 7.0 ? I 
3 I 6.0 2 . 0 Q 2.0 0 . 2 I 13 . 0 Q 6.l+E 4.0 
4 p 5.0 0 A 5.0 0 p 9 . 3 A 11.0 
5 F 4.0 1.0 G 4.0 1. 0 F 11. 0 G 10.6 
6 N+D 8.0 1.5 (D) N+D 3 . 4 ( D) 
7 a (R) ? 0 V 4.0 0 .2 
e 
R 1 . 6 fv 2.9 
8 L 5.5 1. 0 L 7.7 
9 
b 
T 4.0 2.0 ( 0 . 2) 
g 
T 3 . 6 
10 I 2.2 0.2 I 6.3 
11 G 2.0 ? G 6. 5 
12 E 2.0 ? E 6.0 
13 G 1. 0 ? G 5.2 
14 C Q 1.2 ? 
d 
3.0 ? (E 2.0) DP Q 0.1 
15 Q 0.2 0.1 DP 4.0 ? h Q 1.0 (E 1.0) 
16 H 1. 0 ?(0.05) DP 3.0 0.2 l 
17 (H 0.05) 
18 
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Table V Caption. 
The values in manual sequencing are relative peak areas. 
The repetitive yield was about 85 %. Values in automated 
sequencing are in nmoles. Carry over refers to residues found in 
the subsequent cycle where it can be identified as such - (?) 
indicates where this cannot be done for technical reasons of peak 
separation or a repeated residue. 
a R expected but 3 smaller peaks found instead. 
b T only present as dehydrothreonine and carried over for 3 
cycles . 
C 
Q only a single major peak present. 
d DP indicates presence of peak eluting at 1 . 5 minutes and not 
present in prior cycles. 
e R identified as a small peak . 
f 
V low yield of this carboxy- terminal residue. 
g T identified as a triplet - the extra two peaks being 
dehydoalanine adducts with the dithiothreitol. 
h Q identifiable above carry-over. 
i 
no residue seen. 
The early eluting DP peak could not be separated in the 
a utomated method . 
128 
more glutamine predominant at cycle 14 and the putative dipeptide 
predominant at cycle 15. 
Automated sequencing of the carboxy-terminal peptide gave 
essentially similar results. Threonine was seen as a 
characteristic triplet and arginine and valine gave low yields at 
cycle 7. At c ycle 14, glutamic acid and small amounts of 
glutamine were found. Glutamine and possibly carried-over 
glutamic were seen at cycle 15. The system did not permit the 
visualisation of very early eluting material. Histidine was not 
seen at all. The glutamine expected at cycle 3 was found partly 
as glutamic aci d and this degradation could be expected to 
increase with each cycle perhaps accountin g for glutamic acid 
instead of glutamine as the main component at cycle 14. (The 
glutamic acid is derived from the chemical deamidation of 
glutamine and is not the result of isopeptide bond hydrolysis 
although partial enzymatic deamidation or transamidation e.g. by 
transglutaminase cannot be excluded). 
Using the known sequence of the human fibrinogen t-chain the 
sequencing data could be resolved into a dipeptide cross-linked 
at lysine 406 and either glutamine 398 or 399 (residues 6 and 13 
or 14 from the carboxy-terminal end of the t-chain) with the loss 
of residues 401-404 that occur between the cross-link sites of 
both antiparallel cross-linked i-chains. This effectively 
cleaves the D-dimer into two monomers and the cross-linked di-z-
chain into two symmetrical fragments consisting of a cross-linked 
dipeptide with the loss of 4 amino acids. 
The sequence is therefore equivalent to the original fibrinogen 
sequence of -
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385 KI IP F N R LT I G E G 
405 A 
[where (* X *) indicates a cros s -lin k site] . Th ere is 




and possibl y also 
399
0 and 
400H in subfractions of the peptid e . 
A degree of heterogeneity seems to exist in two respects viz. -
1 .) The cross-linked glutamine would appear to be either 
residue 14 or 15 wit h 15 predominating. 
2 .) The loss of carboxy-terminal amino acids may include both 
histidines and possibly even a leucine (residue s 16, 17 
and 18 of the peptide. There ma y also be deamidation o f 
some of the glutamines near the cross-lin k site . 
However, the amino-terminal residue of the secondar y sequence is 
unequivocally alanine with the following lysine not appearing in 
the second cycle and presumably still cross-linked to the 
glutamines at either sites 14 or 15. 
The recovery of carboxy-terminal peptide, quantitated by the 
lysine content of Peaks A and B , (Figure 3), accounted for 60 % of 
the expected yield from the D-dimer used as starting material. 
Considering that only central components of peaks, e.g. as 
indicated by fluorescence, were collected the slightly 
heterogeneous carboxy-terminal peptides probably represented the 
major component and the existence of other variants was unlikely. 
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4. DISCUSSION 
Fibrinogen is a molecule so perfectly adapted to its 
function that it has remained unchanged for 45 0 million years. 
The domainal nature of the molecule is essential both for it s 
primary function, that of clot formation, an d for the subsequent 
dissolution of the clot due to lysis at plasmin-vulnerable 
regions between the D and E domains. Fibrinolysis, in vivo, is 
achieved by plasminolysis at defined sites, releasing the E and D 
domains, but not affecting any D-domains cross-linked by 
transglutaminase. In the case of D-dimer removal of calcium 
exposes more sites for plasmin cleavage, putatively i-356 / 357 
and/or t-g 373 / 374 resulting in the excision of a cross-linked 
peptide of molecular weight+ 10,000 daltons, and therefore 
separation into monomers (Lindsey et al, 197 8) . 
southan et al (1985) report that conversion of Fg-D-Ca to 
Fg-D-EDTA occurs by progressive cleavage of three peptides 
t-3 03 -356, 357-373 and 373-405 . The last two peptides fo rm part 
of the polymerization site of the D-d omain, as well as the site 
that reacts with platelets and staphylococci. These D-monomers 
have lost the ability to inhibit polymerization and are unable to 
cause platelet aggregation or staphylococcal clumping . The 
requirement for calcium removal probably indicates that cleavage 
of the carboxy-terminal end of the t-chain by plasmin is 
physiologically irrelevant. Enzymes capable of separating the 
D-domains of fibrin in the natural state at neutral pH have not 
been reported. 
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There are three aspects to the work reported here: 
i.) the isolation and characterization of an enzyme from 
puffadder (Bitis arietans) venom that is able to separate the 
cross-linked D-domain of D-dimer derived from fibrin, and 
ii.) the nature of the cleavage affected by this enzyme i.e. 
whether there is direct cleavage of the E-(i-glutamyl)-lysine 
isopeptide bond or whether cleavage is due to endopeptidase 
activity of the enzyme, resulting in two D-monomer molecules. 
iii.) the immunological reactivity of the crosslink region 
with antibodies. 
Preliminary work on the action of puffadder on D-dimer was 
done using crude puffadder venom in which it was noted that 
cleavage of fluorescent-D-dimer to fluorescent- D- monorner was time 
and concentration dependent. The action of the puffadder venom 
on the dansyl-cadaverine labelled D-dimer results in th e 
formation of apparently symmetrical monomers with onl y one 
species of g-chain either fluorescent or non-fluorescent. 
Asymmetrical cleavage products with g-chains having a size 
difference of 10 or more residues can be readil y detected on SDS-
PAGE gels with flat gradients (Purves and Lindsey, 1978). The 
enzyme from puffadder venom cleaved non-fluorescent D-dimer in 
exactly the same manner as the fluorescently labelled D-dimer , 
again giving rise to apparently symmetrical products . Early on 
in the work it was noted that after prolonged incubation of 
substrate and enzyme or using high concentrations of enzyme a 
double band appeared on SDS-PAGE gels, one equivalent to normal 
D-monomer and one with a slightly smaller molecular weight that 
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was called D-PAV-monomer. Using SDS-PAGE gels with reducing 
conditions smaller molecular weight of D-PAV-monomer was found to 
be due to cleavage of the J3-chain, the ~-chain remaining intact. 
There was no indication of the asymmetrical products that might 
be produced if there was endopeptidase activity at the carboxy 
terminal end of th e 8-chain. 
Cleavage of the di-~ bond appears to precede and be 
independent o f the progressive reduction in size of the ft-chain. 
Thu s the D-dimer cleavage into monomers appears to occur before 
shortening of the ~-chain and is also not dependent on the 
calcium stabilized conformation producing resistance to continued 
plasmin cleavage (Purves & Lindse y 1978; Haverkate & Timan 
1977 ) . The purified enzyme gave exactl y the same results with 
fluorescent and non-fluorescent-D-dimer as substrate. The 
caseinolytic activity found in peak l of the Sephadex Gl00 gel-
filtration of PAV protease was associated with esterase activity 
and not wit h D-dimer cleavage activity. The D-dimer cleavage 
activit y found in peak three was associated with the second and 
major peak of caseinolytic activity. The effect of the enzyme on 
fibrinogen was very rapid digestion of thea(-chain, slower 
digestion of the !3-chain with the j-chain left intact. The effect 
of added zinc on cleavage of f-D-dimer by PAV protease was 
monitored by change in absolute fluorescence using a fluorimeter. 
The effect of added zinc was to increase the loss of absolute 
fluorescence immediately but the same final value was reached 
whether the zinc was added at zero time or later. The 
potentation was of the order of ten-fold. 
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These changes in fluorescence probably reflect changes in 
t hE hydrophobic environment of the dansyl group on the one 
blocked cross-link site. This is likely because both cross-link 
s i~es mu st lie between the large D-domains. Only metal chelator s 
e. s . EDTA were effective in inhibitin g PAV protease. Mercury 
co~pounds, methyl ketones and inhibitors o f bacterial origon had 
no effect on PAV pr otease ability t o cleave D-dimer. EDTA had no 
ef:ect on the esteras e activity of crude PAV enzyme, but totall y 
in jibi ted cleavage of D-dimer. An equimolar amoun t of Zn an d 
ED~A added to PAV enzyme did not inhibit the p rotease. However, 
PA~ venom collected in the presence of EDTA showed no D-dimer 
activity . Dialysis of the EDTA-PAV venom against buffers 
cont aining zinc ions did not restore D-dimer cleavage activity . 
Tr.is ma y be due to auto digestion of the venom in the absence of 
calcium ions reported b y Van der Walt (1971). The enzyme has a 
re 
zinc moiety that once removed is unable to be~stored. Many snake 
ve nom enzymes have been shown to be zinc dependent cationic 
me~allo-proteinase s wit h a molecular weight of between 20,00 0 and 
30,000 daltons (Evans, 1981; Dyr et al, 198 3 ; Pandya & 
Budzynski, 1984). Possibly several of them will be the same as 
or similar to the enzyme in puffadder venom. Three of the other 
snake venoms tested showed a similar activity with respect to D-
dimer as puffadder venom. The enzyme does seem to be confined to 
snakes from Viperidae and Crotalidae and not found in Elapid 
snakes such as Dendroaspis polylepis (boomslang), or Echinis 
carinatus. 
several other proteases tested degraded the D-dimer molecule 
but showed no D-dimer cleavage into monomers . Clostripain, 
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leucine amino peptidase and cathepsin D wer e unable t o degrade 
D-dimer at all. 
The active f ractions isolated from AcA 54 gel filtration 
wer e applied to an HPLC system a nd further fractionated into 
sever al peaks , one of whic h showed D-dime r cleavage activity. 
Further pur i fic ation wa s not attempt e d , as it wa s fou nd that the 
zinc moeity of th e enz yme may be removed r e ndering the enz yme 
inactive. Although t hree bands wer e observed on SDS-PAGE gels, 
th e smaller proteins are pr o bably associated in solution since 
the y emerge at the s a me hydrodynamic radius as the larger 
proteins on molecula r sieving. 
The HPLC results show D-dimer cleavage activity associated 
wit h a protein o f +25,000 daltons on SDS-PAGE gels a s compared to 
mo lecular weight standards. In conclusion the p rotease has a 
de finite requirement for zinc ions, is active at pH's ranging 
from 7 to 9 with an optimum at about pH 8 . 0 . It is unaffected by 
inhibi tor s suc h as DFP, t he mercur y compounds, bacterial derived 
inhibi tors, or methylketones (Van der Walt , 1970). 
It h a s no affects on substrates such as TAME, ATEE, BTEE or the 
Chromozym substrates. It is unable to cleave small peptides such 
as met-phe-gly, gly-leu-tyr , gly-leu, gly-ile and poly L-ty r, but 
randomly hydrolyzed three different protein substrates eg. casein 
into a large number of smaller peptides sugge ~ting that a certain 
minimum number of amino acids are required (Van der Walt, 1970). 
PAV protease degrades fibrinogen rendering it incoaguable 
within a short time, probably due to the rapid degradation of the 
a-chain. It does not degrade the t-chain unlike plasmin which 
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attacks all three chains o f fibrinogen. 
The purified PAV protease was utilized to stud y the cross-
link sites of the i -c hains o f the D-domain of fibrin . 
Sinc e the cleavag e of D- dimer y ielded apparently symmetrical 
monomers without ~-chain shortening or loss of substituted lysine 
analogues e.g. dans y l cadaverine, the simples t explanation woul d 
have been an isopeptide bond cleavage especially if, a s has been 
assumed, one of the cross-link sites is alwa y s blocked by any 
substituent (Table VI). 
The results provide the explanation for the abilit y of 
puffadder venom protease t o produce cleavage of D-dimer into 
monomers. The · presence o f the cross-links be tween the v-chains 
of D-dime r provides a potential new conformation for selective 
~-c hain cleavage. The cleavage occurs between the cross-link 
sites i .e. between the lysine and glutamine acids 6 and 14 (or 
13) residues from the carboxy-terminal end of the dA-chain 
(Ta ble VI) . Symmetrical products would be produced if two cross-
links were present, irrespective of whet her the cross-link site 
is at either glutamine residue (Table VI, E & F). However, the 
presence of only one cross-link due to a substitution should lead 
to assymmetrical products (Table VI, D) with differences as much 
as 18 residues. If both chains are nevertheless cleaved, a 
smaller difference of 7 residues between substituted and doubly 
cross-linked chains would be found (Table VIC). 
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Table VI : Crosslink configurations of the human di-t-chain 
carboxy-terminal CNBr peptide and the mode of puffadder venom cleavage 








( * ) * 
C . Cleavage at the cross-link site by PAV - assymetric fragments 
- 7 residue difference 
:---------------1 4--c n-6-----c 
X 
c ----- 6-n c--14---------------. f( g-11) 
* 
D. Cleavage at a single cross-link site - assyrnetric fragments 
- 18 residue diffe rence 
:---------------14-------6-----c 




f - (~-11) 
E. Cross-lin k not inhibited by a substitution on adjacent residues 
* 
:--------------14-1 3----- 6-----c 
X X 
c -----6-----1 3-1 4-----------------: 
* 
















Table VI Caption. 
Th e diagram represents the cross-linked car boxy-terminal end of 
the i-chain fragments after cyanogen bromide cleavage. 
( : ) - residue after cyanoge n bromide cleavage 
(n) - amino-terminal residu e 
(c) - carboxy-terminal residue 
(f) - fluorescent substituent if dansyl-cadaverine used as 
lysine analogue for transglutaminase activity. 
(X ) - site of isopeptide cross-lin k. 
(*) - substituent 
(i-4,i-11,8+7) - peptides differing from the i-chain residue number. 
The natural (unsubstituted) cross-linked t-chains described 
in this report, appear to have both posssible cross-links 
present. The recovery of the cross-linked dipeptide was at least 
60% of expected which implies that the predominant species was 
analysed. 
The original assignment of the cross-link site was at 
glutamine 14 from the carboxy-terminal end based on [ 14c]-glycine 
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ethyl ester substitution by transglutaminas e an d the lesser 
amount of substitution at glutamine 1 3 was attributed to the 
small size of the non-natural substrat e . Model building also 
suggested that th e glutamine, 14 residues from the carbox y-
terminal end was advantageousl y positioned on the a - helix being 
in the same sector a s th e lysine, 6 resid ues f rom the carbox y-
terminal end (Doolittle et al, 1972 ) . However , labelling with a 
substituent is not the same a s cros s-linking . 
our data suggest t h at there i s cros s - linking at either 
glutamine with perhaps the glutamine at position 13 fr om the 
carboxy-terminal end (residue ~ 399) being p redom in ant . This 
leaves open the possibility that both substitut ion an d cross-
lin k ing could occur on the same molecule (Fig. VI, E + F) . This 
would simplify exp lanations for the symmetr y o f substituted 
products after puffadder venom protease cleavage (Table VI, G). 
These questions will have to be resolved by direct sequencing of 
the substituted chains cleaved by puffadder venom protease . 
Alanine (residue 419) was consistently found at the newly 
generated amino-terminal end but the carboxy-terminal end was 
heterogeneous to a certain extent (e.g. sub-stoichiometric 
amount s of histidine). This is an adequate explanation for the 
failure of previous attempts to determine the carboxy-terminal 
sequence by direct methods, e.g. carboxypeptidase-Y and tritium 
labelling (data not shown). The proximity of the cross-link site 
to the heterogeneous carboxy-terminal residues is another 
perturbing factor. 
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Table VII : Comparison of carboxy-terminal sequences at the 
cross-1 ink sites of a bb . C 
d 
JA-chain. rat, ov1ne, human and lamprey 
* + + + + * 
Rat s I G D G Q Q H H N G G s K Q V G 
Bovine A I G Q G Q Q H Q L G G A K Q A G 
Human T I G Q G Q Q H H L G G A K Q A G 
Lampre y L s G H G G Q Q Q s K Gf N s R G 
14 13 12 11 1 0 9 8 7 6 5 4 3 
* * 
* Indicates cross-link sites. The numbering begins at the 
car boxy-terminal end of the ~-cha in . 






(+) Possible consensus for puffadder venom protease specificity. 
a 
(Hamandberg et al, 1985) 
b 
(Chen & Doolittle, 1971) 
C 
(Henschen et al, 1983) 
d 
(Strong et al, 1985) 
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Since bovine and rat D-dimers are also susceptible to PAV 
proteas e there is an indication o f a possible consensus (Table VII) 
of either di-glycyl or histidyl- glutamyl re sidues and t he presence 
o f the cross-link. D- d ime r from hag fish , a close relative of the 
lamp re y , also appears to be cleaved by puff add er venom protease 
(dat a not shown). However nothing is known about the cross-link 
site in hag fish . If similar to th e lamprey , there will be fewer 
residue s bet ween the cros s -links. The r e are only three residues 
between the cross-links o f lamp re y , and there coul d possibly be 
only on e or two de pend in g which glutamine is utilized for cross-
linking . Susceptibility of the lamprey ~-c hain cross-link to 
puf fadder venom protease is still to be tested . 
The possibility that the site-specific endopeptidase is 
contaminated by an exopeptidase tha t generates the heterogeneous 
ends cannot be excluded at present (Pu rves et al, 1986). 
Since the presence of the cros s -links provide the 
specificit y necessary fort-chain cleavage by t he puffadder venom 
protease this suggests that the fibrinogen conformation is 
sufficiently altered so that new epitopes might be created and 
raises the possibility that monoclonal antibodies could be 
produced wit h specificity for cross-linked fibrin using puffadder 
venom-cleaved peptides as antigen. 
The assays for fibrin(ogen) degradation products (FDPs) will 
only become more reliable as more specific monoclonal antibodies 
are developed. Synthetic peptides with the same sequence as the 
amino-terminal ends of the oJ.. and fl-chains of fibrin, have been 
the most frequently used antigens for raising monoclonal antibodies. 
Little attention has so far been given to the t-chain except for 
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the raising of a monoclonal antibody that recognises cross-linked 
D-dimer (Ry latt et al, 19 83) and attempts to exploit the 
enhanced reaction of anti- D-dimer antibodies (8-fold more than 
wit h D- monomer ) (Purves et al, 1980). The carboxy-terminus of 
the i-chain has not yet been a source of antigenic material for 
antibodie s that could recognise the cross-link epitope and 
distinguish unequivocally between fibrinogen and fibrin degradation 
product s in plasma and serum. PAV protease may offer a way of 
exposing useful epitopes in the carboxy-terminal end of the i-
chain. The cross-linked peptide from D-dimer can be isolated from 
a calcium free plasmin digest of D-dimer (Lindsey et al, 1978). 
This peptide could be used as a possible antigen for monoclonal 
antibodies. PAV protease cleaves D-dimer between the reciprocal 
cross-link sites, thus each D-PAV-monomer must retain one cross-
link site. The carboxy-terminal peptide from the i-chain of 
D-PAV- monomer or a synthetic peptide based on its structure, is 
another possible antigen for a monoclonal antibody for this 
region of cross-linked FDPs. In the preliminary work presented 
here D- PAV- monomer did not react with the monoclonal antibody to 
D-dimer, either in the radioimmunoassay or in the Dimertest 
agglutination assay. D-monomer from plasmin digested fibrinogen 
also gave a negative result with the radioimmunoassay and the 
Dirnertest agglutination assay. A calcium free plasmin digest of 
D-dimer gave positive agglutination with Dimertest beads even 
after 18 hours digestion. This could be due to the association of 
the excised cross-linked peptide with the D-monomers 
(Purves et al, 1980). 
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